<SEC-DOCUMENT>0001493152-24-010974.txt : 20240322
<SEC-HEADER>0001493152-24-010974.hdr.sgml : 20240322
<ACCEPTANCE-DATETIME>20240322160523
ACCESSION NUMBER:		0001493152-24-010974
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20240320
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240322
DATE AS OF CHANGE:		20240322

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Beyond Air, Inc.
		CENTRAL INDEX KEY:			0001641631
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				473812456
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38892
		FILM NUMBER:		24775185

	BUSINESS ADDRESS:	
		STREET 1:		900 STEWART AVENUE
		STREET 2:		SUITE 301
		CITY:			GARDEN CITY
		STATE:			NY
		ZIP:			11530
		BUSINESS PHONE:		516-665-8200

	MAIL ADDRESS:	
		STREET 1:		900 STEWART AVENUE
		STREET 2:		SUITE 301
		CITY:			GARDEN CITY
		STATE:			NY
		ZIP:			11530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AIT Therapeutics, Inc.
		DATE OF NAME CHANGE:	20170117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KokiCare, Inc.
		DATE OF NAME CHANGE:	20150507
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:XAIR="http://beyondair.net/20240320">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_XAIR_beyondair.net_20240320 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20240320_20240320 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001641631 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:AmendmentFlag" id="ixv-497">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:EntityCentralIndexKey" id="ixv-498">0001641631</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="xair-20240320.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-03-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001641631</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-20</xbrli:startDate>
        <xbrli:endDate>2024-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_908_edei--DocumentType_c20240320__20240320_zwsmTZMdnWca"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:DocumentType" id="ixv-518">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span style="text-decoration: underline"><span id="xdx_90C_edei--DocumentPeriodEndDate_c20240320__20240320_z1TkbcdavdA5"><ix:nonNumeric contextRef="AsOf2024-03-20" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-519">March 20, 2024</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_90B_edei--EntityRegistrantName_c20240320__20240320_zDbcGEUQhol2"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:EntityRegistrantName" id="ixv-520">BEYOND
AIR, INC</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20240320__20240320_zmE5DJ2MN3S6"><ix:nonNumeric contextRef="AsOf2024-03-20" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-521">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityFileNumber_c20240320__20240320_zLTyb9SjyK7j"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:EntityFileNumber" id="ixv-522">001-38892</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20240320__20240320_zXgUHq6PuHE1"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:EntityTaxIdentificationNumber" id="ixv-523">47-3812456</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20240320__20240320_z7UaOyRPzgV8"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:EntityAddressAddressLine1" id="ixv-524">900
Stewart Avenue</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressAddressLine2_c20240320__20240320_zpdCubmEbfU5"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:EntityAddressAddressLine2" id="ixv-525">Suite
301</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityAddressCityOrTown_c20240320__20240320_zzu8WfISN6dc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:EntityAddressCityOrTown" id="ixv-526">Garden
City</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20240320__20240320_zjOxrNiksTJc"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:EntityAddressStateOrProvince" id="ixv-527">NY</ix:nonNumeric> </span></span></b><b><span id="xdx_906_edei--EntityAddressPostalZipCode_c20240320__20240320_zC0w6imlsWmi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:EntityAddressPostalZipCode" id="ixv-528">11530</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_90D_edei--CityAreaCode_c20240320__20240320_zb9aQqPOr3qe"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:CityAreaCode" id="ixv-529">(516)</ix:nonNumeric></span>
<span id="xdx_909_edei--LocalPhoneNumber_c20240320__20240320_zJSAKXJdBGvf"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:LocalPhoneNumber" id="ixv-530">665-8200</ix:nonNumeric></span> </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">N/A</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report.)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--WrittenCommunications_c20240320__20240320_z7JoUZOue843"><ix:nonNumeric contextRef="AsOf2024-03-20" format="ixt:booleanfalse" name="dei:WrittenCommunications" id="ixv-531">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SolicitingMaterial_c20240320__20240320_zkdTHrkN7E08"><ix:nonNumeric contextRef="AsOf2024-03-20" format="ixt:booleanfalse" name="dei:SolicitingMaterial" id="ixv-532">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementTenderOffer_c20240320__20240320_zAmSHlEaSu0g"><ix:nonNumeric contextRef="AsOf2024-03-20" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer" id="ixv-533">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20240320__20240320_zr1iHocrqjfi"><ix:nonNumeric contextRef="AsOf2024-03-20" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer" id="ixv-534">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20240320__20240320_zD5vq1PqmaAe"><ix:nonNumeric contextRef="AsOf2024-03-20" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="ixv-535">&#9744;</ix:nonNumeric></span>
Emerging growth company</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--Security12bTitle_c20240320__20240320_zWZqFVH8IJYg"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:Security12bTitle" id="ixv-536">Common
    Stock, par value $.0001 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--TradingSymbol_c20240320__20240320_zN4e2FZft5Bh"><ix:nonNumeric contextRef="AsOf2024-03-20" name="dei:TradingSymbol" id="ixv-537">XAIR</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--SecurityExchangeName_c20240320__20240320_z89MQDkRPshe"><ix:nonNumeric contextRef="AsOf2024-03-20" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-538">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 20, 2022, Beyond Air, Inc., a Delaware corporation (the &#8220;Company&#8221;), entered into a securities purchase agreement (the
&#8220;Securities Purchase Agreement&#8221;) with certain institutional and accredited investors, including certain directors and
officers of the Company, (the &#8220;Purchasers&#8221;) pursuant to which the Company sold, in a registered direct offering,
an aggregate of (i) 9,638,556 shares (the &#8220;Shares&#8221;) of common stock, par value $0.0001 per share, of the Company (&#8220;Common
Stock&#8221;); and (ii) 9,638,556 common stock purchase warrants (the &#8220;Common Stock Warrants&#8221;) to purchase up to 9,638,556
shares of Common Stock (the &#8220;Common Stock Warrant Shares&#8221;). The combined offering price per Share and accompanying Common
Stock Warrant is $1.66. Subject to certain ownership limitations, each Common Stock Warrant is immediately exercisable upon issuance
at an exercise price of $2.25 per share and expires three years from the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares, Common Stock Warrants and Common Stock Warrants Shares were offered pursuant to a &#8220;shelf&#8221; registration statement
on Form S-3 (Registration No. 333-262311), which was declared effective by the Securities and Exchange Commission (the &#8220;SEC&#8221;)
on February 1, 2022, as supplemented by a prospectus supplement and accompanying base prospectus dated March 20, 2024 filed with the
SEC on March 22, 2024 pursuant to Rule 424(b)(5) promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Securities Purchase Agreement contained customary representations and warranties. The offering closed on March 22, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 20, 2024, the Company also entered into a placement agency agreement (the &#8220;Placement Agency Agreement&#8221;) with Roth Capital
Partners, LLC and Laidlaw &amp; Company (UK) Ltd. (the &#8220;Co-Placement Agents&#8221;) as the co-placement agents in connection with
the offering. Pursuant to the terms of the Placement Agency Agreement, the Co-Placement Agents agreed to use their reasonable best efforts
to arrange for the sale of the securities in the offering. As compensation to the Co-Placement Agents, the Company paid
the Co-Placement Agents a cash fee of 7% of the aggregate gross proceeds raised in the offering and the reimbursement of certain
expenses and legal fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company received net proceeds of approximately $14.6 million from the offering, after deducting the estimated offering expenses payable
by the Company, including the Co-Placement Agents fees. The Company intends to use the net proceeds from the offering to
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fund commercial sales development, research, working
capital and other general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under the Securities Purchase Agreement, until 90 days after March 22, 2024, subject to certain exceptions, neither
the Company nor any of its subsidiaries shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance
of any Common Stock or Common Stock equivalents or (ii) file any registration statement or amendment or supplement thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
addition, from the date of the Securities Purchase Agreement, the Company has agreed not to enter into variable rate transactions (as
defined in the Securities Purchase Agreement) for a period of six (6) months from the closing of this offering, subject to certain exceptions</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions
to closing, indemnification obligations of the Company and the Purchasers, including for liabilities under the Securities Act,
other obligations of the parties and termination provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
form of Placement Agency Agreement, Securities Purchase Agreement and Common Stock Warrant, are filed as Exhibits 1.1,
10.1 and 4.1, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The above descriptions of the
terms of the Placement Agency Agreement, Securities Purchase Agreement and Common Stock Warrant are qualified in their entirety by reference
to such exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2024, the Company issued a press release announcing the pricing of the offering. A copy of the press release announcing this
matter is filed as Exhibit 99.1 to this Report and is incorporated by reference into this Item 8.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex1-1.htm">Form of Placement Agency Agreement dated March 20, 2024, by and between Beyond Air, Inc. and Roth Capital Partners, LLC and Laidlaw &amp; Company (UK) Ltd.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common Stock Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Opinion of Sichenzia Ross Ference Carmel LLP</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1<sup>+</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0pt 0"><a href="ex10-1.htm">Form of Securities Purchase Agreement dated March 20, 2024, by and between Beyond Air, Inc and the Purchasers</a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Sichenzia Ross Ference Carmel LLP (contained in Exhibit 5.1)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated March 20, 2024</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Item 601(a)(5) of Regulation S-K, schedules have been omitted and will be furnished on a supplemental basis to the Securities
    and Exchange Commission upon request.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BEYOND
    AIR, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 22, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>By:</i></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Steven A. Lisi</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven
    A. Lisi</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLACEMENT
AGENCY AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
20, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roth
Capital Partners, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">888
San Clemente Drive, Suite 400</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newport
Beach, CA 92660</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
&amp; Company (UK) Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">521
Fifth Avenue, 12<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10175</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introduction</B>.
Subject to the terms and conditions herein (this &ldquo;<U>Agreement</U>&rdquo;), Beyond Air, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
hereby agrees to sell up to an aggregate of $16,000,003 of registered securities of the Company, including, but not limited to, shares
(the &ldquo;<U>Shares</U>&rdquo;) of the Company&rsquo;s common stock, $0.0001 par value per share (the &ldquo;<U>Common Stock</U>&rdquo;),
Pre-Funded Common Stock purchase warrants to purchase shares of Common Stock (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;) and Common
Stock purchase warrants to purchase shares of Common Stock (the &ldquo;<U>Common Warrants</U>&rdquo; and, together with the Pre-Funded
Warrants, the &ldquo;<U>Warrants</U>&rdquo; and collectively with the Shares, the &ldquo;<U>Securities</U>&rdquo;) directly to various
investors (each, an &ldquo;Investor&rdquo; and, collectively, the &ldquo;<U>Investors</U>&rdquo;) through Roth Capital Partners, LLC
(&ldquo;<U>Roth</U>&rdquo;) and Laidlaw &amp; Company (UK) Ltd. (&ldquo;<U>Laidlaw</U>&rdquo;, and each of Roth and Laidlaw, a &ldquo;<U>Placement
Agent</U>&rdquo; and collectively, the &ldquo;<U>Co-Placement Agents</U>&rdquo;) as co-placement agents. The documents executed and delivered
by the Company and the Investors in connection with the Offering (as defined below), including, without limitation, a securities purchase
agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), shall be collectively referred to herein as the &ldquo;<U>Transaction Documents</U>.&rdquo;
The purchase price to the Investors for each Share is $1.66 and the exercise price to the Investors for each share of common stock issuable
upon exercise of the Common Warrants is $2.25. The Co-Placement Agents may retain other brokers or dealers to act as sub-agents or selected-dealers
on its behalf in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby confirms its agreement with the Co-Placement Agents as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1. Agreement to Act as Placement Agent. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On the basis of the representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions
of this Agreement, the Co-Placement Agents shall be the exclusive placement agents in connection with the offering and sale by the Company
of the Securities pursuant to the Company&rsquo;s registration statement on Form S-3 (File No. 333-262311) (the &ldquo;<U>Registration
Statement</U>&rdquo;), with the terms of such offering (the &ldquo;<U>Offering</U>&rdquo;) to be subject to market conditions and negotiations
between the Company, the Co-Placement Agents and the prospective Investors. The Co-Placement Agents will act on a reasonable best efforts
basis and the Company agrees and acknowledges that there is no guarantee of the successful placement of the Securities, or any portion
thereof, in the prospective Offering. Under no circumstances will the Co-Placement Agents or any of their &ldquo;Affiliates&rdquo; (as
defined below) be obligated to underwrite or purchase any of the Securities for its own account or otherwise provide any financing. The
Co-Placement Agents shall act solely as the Company&rsquo;s agents and not as principal. The Co-Placement Agents shall have no authority
to bind the Company with respect to any prospective offer to purchase Securities and the Company shall have the sole right to accept
offers to purchase Securities and may reject any such offer, in whole or in part. Subject to the terms and conditions hereof, payment
of the purchase price for, and delivery of, the Securities shall be made at one or more closings (each a &ldquo;<U>Closing</U>&rdquo;
and the date on which each Closing occurs, a &ldquo;<U>Closing Date</U>&rdquo;). As compensation for services rendered, on each Closing
Date, the Company shall pay to the Co-Placement Agents the fees and expenses set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
An aggregate cash fee equal to 7.0% of the gross proceeds received by the Company from the sale of the Securities at each Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Company also agrees to reimburse Co-Placement Agents&rsquo; expenses (with supporting invoices/receipts) of $50,000 payable immediately
upon the Closing of the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The term of the Co-Placement Agents&rsquo; exclusive engagement will be as set forth in the certain letter agreement, dated as of February
16, 2024, by and among the Company, Roth and Laidlaw (the &ldquo;<U>Engagement Agreement</U>&rdquo;). Notwithstanding anything to the
contrary contained herein, the provisions concerning confidentiality, indemnification and contribution contained herein and therein and
the Company&rsquo;s obligations contained in the indemnification provisions will survive any expiration or termination of this Agreement,
and the Company&rsquo;s obligation to pay fees actually earned and payable and to reimburse expenses actually incurred and reimbursable
pursuant to Section 1 hereof and which are permitted to be reimbursed under FINRA Rule 5110(f)(2)(D), will survive any expiration or
termination of this Agreement. Nothing in this Agreement shall be construed to limit the ability of the Co-Placement Agents or their
Affiliates to pursue, investigate, analyze, invest in, or engage in investment banking, financial advisory or any other business relationship
with Persons (as defined below) other than the Company. As used herein (i) &ldquo;Persons&rdquo; means an individual or corporation,
partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government
(or an agency or subdivision thereof) or other entity of any kind and (ii) &ldquo;Affiliate&rdquo; means any Person that, directly or
indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are
used in and construed under Rule 405 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2. Representations, Warranties and Covenants of the Company</B>. The Company hereby represents, warrants and covenants to the Co-Placement
Agents as of the date hereof, and as of each Closing Date, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Securities Law Filings</U>. The Company has filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
the Registration Statement under the Securities Act, which was filed on January 24, 2022 and declared effective on February 1, 2022 for
the registration of the Securities under the Securities Act. Following the determination of pricing among the Company and the prospective
Investors introduced to the Company by the Co-Placement Agents, the Company will file with the Commission pursuant to Rules 430A and
424(b) under the Securities Act, and the rules and regulations (the &ldquo;<U>Rules and Regulations</U>&rdquo;) of the Commission promulgated
thereunder, a final prospectus supplement relating to the placement of the Securities, their respective pricings and the plan of distribution
thereof and will advise the Co-Placement Agents of all further information (financial and other) with respect to the Company required
to be set forth therein. Such registration statement, at any given time, including the exhibits thereto filed at such time, as amended
at such time, is hereinafter called the &ldquo;<U>Registration Statement</U>&rdquo;; such prospectus in the form in which it appears
in the Registration Statement at the time of effectiveness, together with any preliminary prospectus supplement relating to the Offering,
is hereinafter called the &ldquo;<U>Base Prospectus</U>&rdquo;; and the final prospectus supplement, in the form in which it will be
filed with the Commission pursuant to Rule 424(b) (including the Base Prospectus as it may be amended or supplemented) is hereinafter
called the &ldquo;<U>Final Prospectus</U>.&rdquo; The Registration Statement at the time it originally became effective is hereinafter
called the &ldquo;<U>Original Registration Statement</U>.&rdquo; Any reference in this Agreement to the Registration Statement, the Original
Registration Statement, the Base Prospectus, or the Final Prospectus shall be deemed to refer to and include the documents incorporated
by reference therein (the &ldquo;<U>Incorporated Documents</U>&rdquo;), if any, which were or are filed under the Securities Exchange
Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), at any given time, as the case may be; and any reference in this Agreement
to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect to the Registration Statement, the
Original Registration Statement, the Base Prospectus, or the Final Prospectus shall be deemed to refer to and include the filing of any
document under the Exchange Act after the date of this Agreement, or the issue date of the Base Prospectus, or the Final Prospectus,
as the case may be, deemed to be incorporated therein by reference. All references in this Agreement to financial statements and schedules
and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set
forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus, or the Final Prospectus (and all other references
of like import) shall be deemed to mean and include all such financial statements and schedules and other information which is or is
deemed to be incorporated by reference in the Registration Statement, the Base Prospectus, or the Final Prospectus, as the case may be.
As used in this paragraph and elsewhere in this Agreement, &ldquo;<U>Time of Sale Disclosure Package</U>&rdquo; means the Base Prospectus,
any subscription agreement between the Company and the Investors, and any issuer free writing prospectus as defined in Rule 433 of the
Act (each, an &ldquo;<U>Issuer Free Writing Prospectus</U>&rdquo;), if any, that the parties hereto shall hereafter expressly agree in
writing to treat as part of the Time of Sale Disclosure Package. The term &ldquo;<U>any Prospectus</U>&rdquo; shall mean, as the context
requires, the Base Prospectus, the Final Prospectus, and any supplement to either thereof. The Company has not received any notice that
the Commission has issued or intends to issue a stop order suspending the effectiveness of the Registration Statement or the use of the
Base Prospectus or any Prospectus Supplement or intends to commence a proceeding for any such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Assurances</U>. The Original Registration Statement, as amended, (and any further documents to be filed with the Commission) contains
all exhibits and schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto,
at the time it became effective, complied in all material respects with the Securities Act and the applicable Rules and Regulations and
did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading. The Base Prospectus, and the Final Prospectus, each as of its respective date, comply or
will comply in all material respects with the Securities Act and the applicable Rules and Regulations. Each of the Base Prospectus and
the Final Prospectus, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. The Incorporated Documents, when they were filed with the Commission, conformed in all material respects to
the requirements of the Exchange Act and the applicable Rules and Regulations promulgated thereunder, and none of such documents, when
they were filed with the Commission, contained any untrue statement of a material fact or omitted to state a material fact necessary
to make the statements therein (with respect to Incorporated Documents incorporated by reference in the Base Prospectus or Final Prospectus),
in light of the circumstances under which they were made not misleading. No post-effective amendment to the Registration Statement reflecting
any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change in the information
set forth therein is required to be filed with the Commission. Except for this Agreement, there are no documents required to be filed
with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities
Act or (y) will not be filed within the requisite time period. Except for this Agreement, there are no contracts or other documents required
to be described in the Base Prospectus or Final Prospectus, or to be filed as exhibits or schedules to the Registration Statement, which
have not been described or filed as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Offering Materials</U>. Neither the Company nor any of its directors and officers has distributed and none of them will distribute,
prior to each Closing Date, any offering material in connection with the offering and sale of the Securities other than the Time of Sale
Disclosure Package.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and the Time of Sale Disclosure Package and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of each of this Agreement by the Company and the consummation by it of the transactions contemplated hereby
and thereby and under the Base Prospectus have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Company&rsquo;s Board of Directors (the &ldquo;<U>Board of Directors</U>&rdquo;) or the Company&rsquo;s
stockholders in connection therewith other than in connection with the Required Approvals (as defined in the Purchase Agreement). This
Agreement has been duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the transactions contemplated pursuant
to the Time of Sale Disclosure Package, the issuance and sale of the Securities and the consummation by it of the transactions contemplated
hereby and thereby to which it is a party do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any
Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with,
or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation
of any Lien (as defined in the Purchase agreement) upon any of the properties or assets of the Company or any Subsidiary, or give to
others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the
Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)
subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal
and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except
in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect
(as defined in the Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Certificates</U>. Any certificate signed by an officer of the Company and delivered to the Co-Placement Agents or to counsel for the
Co-Placement Agents shall be deemed to be a representation and warranty by the Company to the Co-Placement Agents as to the matters set
forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Reliance</U>. The Company acknowledges that the Co-Placement Agents will rely upon the accuracy and truthfulness of the foregoing
representations and warranties and hereby consents to such reliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Forward-Looking Statements</U>. No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) contained in the Time of Sale Disclosure Package has been made or reaffirmed without a reasonable basis or has
been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Statistical or Market-Related Data</U>. Any statistical, industry-related and market-related data included or incorporated by reference
in the Time of Sale Disclosure Package, are based on or derived from sources that the Company reasonably and in good faith believes to
be reliable and accurate, and such data agree with the sources from which they are derived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>FINRA Affiliations</U>. There are no affiliations with any FINRA member firm that is participating in the Offering among the Company&rsquo;s
officers, directors or, to the knowledge of the Company, any five percent (5%) or greater stockholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Representations, Warranties and Covenants Incorporated by Reference</U>. Each of the representations, warranties and covenants (together
with any related disclosure schedules thereto) made to the Investors in the Purchase Agreement is hereby incorporated herein by reference
(as though fully restated herein) and is hereby made to, and in favor of, the Co-Placement Agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3. Delivery and Payment</B>. Each Closing shall occur at the offices of the Ellenoff Grossman &amp; Schole LLP, 1345 Avenue of the Americas,
New York, New York 10105 (&ldquo;<U>Placement Agent Counsel</U>&rdquo;) (or at such other place as shall be agreed upon by the Co-Placement
Agents and the Company). Subject to the terms and conditions hereof, at each Closing payment of the purchase price for the Securities
sold on such Closing Date shall be made by Federal Funds wire transfer, against delivery of such Securities, and such Securities shall
be registered in such name or names and shall be in such denominations, as the Co-Placement Agents may request at least one business
day before the time of purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deliveries
of the documents with respect to the purchase of the Securities, if any, shall be made at the offices of Placement Agent Counsel. All
actions taken at a Closing shall be deemed to have occurred simultaneously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4. Covenants and Agreements of the Company</B>. The Company further covenants and agrees with the Placement Agent as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Registration Statement Matters</U>. The Company will advise the Co-Placement Agents promptly after it receives notice thereof of the
time when any amendment to the Registration Statement has been filed or becomes effective or any supplement to the Base Prospectus or
the Final Prospectus has been filed and will furnish the Co-Placement Agents with copies thereof. The Company will file promptly all
reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section
13(a), 14 or 15(d) of the Exchange Act subsequent to the date of any Prospectus and for so long as the delivery of a prospectus is required
in connection with the Offering. The Company will advise the Co-Placement Agents, promptly after it receives notice thereof (i) of any
request by the Commission to amend the Registration Statement or to amend or supplement any Prospectus or for additional information,
and (ii) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective
amendment thereto or any order directed at any Incorporated Document, if any, or any amendment or supplement thereto or any order preventing
or suspending the use of the Base Prospectus or the Final Prospectus or any prospectus supplement or any amendment or supplement thereto
or any post-effective amendment to the Registration Statement, of the suspension of the qualification of the Securities for offering
or sale in any jurisdiction, of the institution or threatened institution of any proceeding for any such purpose, or of any request by
the Commission for the amending or supplementing of the Registration Statement or a Prospectus or for additional information. The Company
shall use its best efforts to prevent the issuance of any such stop order or prevention or suspension of such use. If the Commission
shall enter any such stop order or order or notice of prevention or suspension at any time, the Company will use its best efforts to
obtain the lifting of such order at the earliest possible moment, or will file a new registration statement and use its best efforts
to have such new registration statement declared effective as soon as practicable. Additionally, the Company agrees that it shall comply
with the provisions of Rules 424(b), 430A, 430B and 430C, as applicable, under the Securities Act, including with respect to the timely
filing of documents thereunder, and will use its reasonable efforts to confirm that any filings made by the Company under such Rule 424(b)
are received in a timely manner by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Blue Sky Compliance</U>. The Company will cooperate with the Co-Placement Agents and the Investors in endeavoring to qualify the Securities
for sale under the securities laws of such jurisdictions (United States and foreign) as the Co-Placement Agents and the Investors may
reasonably request and will make such applications, file such documents, and furnish such information as may be reasonably required for
that purpose, provided the Company shall not be required to qualify as a foreign corporation or to file a general consent to service
of process in any jurisdiction where it is not now so qualified or required to file such a consent, and provided further that the Company
shall not be required to produce any new disclosure document. The Company will, from time to time, prepare and file such statements,
reports and other documents as are or may be required to continue such qualifications in effect for so long a period as the Co-Placement
Agents may reasonably request for distribution of the Securities. The Company will advise the Co-Placement Agents promptly of the suspension
of the qualification or registration of (or any such exemption relating to) the Securities for offering, sale or trading in any jurisdiction
or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification,
registration or exemption, the Company shall use its best efforts to obtain the withdrawal thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Amendments and Supplements to a Prospectus and Other Matters</U>. The Company will comply with the Securities Act and the Exchange
Act, and the rules and regulations of the Commission thereunder, so as to permit the completion of the distribution of the Securities
as contemplated in this Agreement, the Incorporated Documents and any Prospectus. If during the period in which a prospectus is required
by law to be delivered in connection with the distribution of Securities contemplated by the Incorporated Documents or any Prospectus
(<U>the &ldquo;Prospectus Delivery Period</U>&rdquo;), any event shall occur as a result of which, in the judgment of the Company or
in the opinion of the Co-Placement Agents or counsel for the Co-Placement Agents, it becomes necessary to amend or supplement the Incorporated
Documents or any Prospectus in order to make the statements therein, in the light of the circumstances under which they were made, as
the case may be, not misleading, or if it is necessary at any time to amend or supplement the Incorporated Documents or any Prospectus
or to file under the Exchange Act any Incorporated Document to comply with any law, the Company will promptly prepare and file with the
Commission, and furnish at its own expense to the Co-Placement Agents and to dealers, an appropriate amendment to the Registration Statement
or supplement to the Registration Statement, the Incorporated Documents or any Prospectus that is necessary in order to make the statements
in the Incorporated Documents and any Prospectus as so amended or supplemented, in the light of the circumstances under which they were
made, as the case may be, not misleading, or so that the Registration Statement, the Incorporated Documents or any Prospectus, as so
amended or supplemented, will comply with law. Before amending the Registration Statement or supplementing the Incorporated Documents
or any Prospectus in connection with the Offering, the Company will furnish the Co-Placement Agents with a copy of such proposed amendment
or supplement and will not file any such amendment or supplement to which the Co-Placement Agents reasonably object.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Copies of any Amendments and Supplements to a Prospectus</U>. The Company will furnish the Co-Placement Agents, without charge, during
the period beginning on the date hereof and ending on the later of the last Closing Date of the Offering, as many copies of any Prospectus
or prospectus supplement and any amendments and supplements thereto, as the Co-Placement Agents may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Free Writing Prospectus</U>. The Company covenants that it will not, unless it obtains the prior written consent of the Co-Placement
Agents, make any offer relating to the Securities that would constitute a Company Free Writing Prospectus or that would otherwise constitute
a &ldquo;<U>free writing prospectus</U>&rdquo; (as defined in Rule 405 of the Securities Act) required to be filed by the Company with
the Commission or retained by the Company under Rule 433 of the Securities Act. In the event that the Co-Placement Agents expressly consent
in writing to any such free writing prospectus (a &ldquo;<U>Permitted Free Writing Prospectus</U>&rdquo;), the Company covenants that
it shall (i) treat each Permitted Free Writing Prospectus as an Company Free Writing Prospectus, and (ii) comply with the requirements
of Rule 164 and 433 of the Securities Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing
with the Commission, legending and record keeping.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Transfer Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Periodic Reporting Obligations</U>. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the
Commission and the Trading Market (as defined in the Purchase Agreement) all reports and documents required to be filed under the Exchange
Act within the time periods and in the manner required by the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Additional Documents</U>. The Company will enter into any subscription, purchase or other customary agreements as the Co-Placement
Agents or the Investors deem necessary or appropriate to consummate the Offering, all of which will be in form and substance reasonably
acceptable to the Co-Placement Agents and the Investors. The Company agrees that the Co-Placement Agents may rely upon, and each is a
third party beneficiary of, the representations and warranties, and applicable covenants, set forth in any such purchase, subscription
or other agreement with Investors in the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>No Manipulation of Price</U>. The Company will not take, directly or indirectly, any action designed to cause or result in, or that
has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Acknowledgment</U>. The Company acknowledges that any advice given by the Co-Placement Agents to the Company is solely for the benefit
and use of the Board of Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Co-Placement
Agents&rsquo; prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Announcement of Offering</U>. The Company acknowledges and agrees that the Co-Placement Agents may, subsequent to the Closing, make
public their involvement with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Reliance on Others</U>. The Company confirms that it will rely on its own counsel and accountants for legal and accounting advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Research Matters</U>. By entering into this Agreement, the Co-Placement Agents do not provide any promise, either explicitly or implicitly,
of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees that the Co-Placement Agents&rsquo;
selection as placement agents for the Offering was in no way conditioned, explicitly or implicitly, on the Co-Placement Agents providing
favorable or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the
Co-Placement Agents have not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened
to change research, a rating or a price target, to the Company or inducement for the receipt of business or compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5. Conditions of the Obligations of the Co-Placement Agents</B>. The obligations of the Co-Placement Agents hereunder shall be subject
to the accuracy of the representations and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the
date hereof and as of each Closing Date as though then made, to the timely performance by each of the Company of its covenants and other
obligations hereunder on and as of such dates, and to each of the following additional conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Accountants&rsquo; Comfort Letter</U>. On the date hereof, the Co-Placement Agents shall have received, and the Company shall have
caused to be delivered to the Co-Placement Agents, a letter from Marcum LLP (the independent registered public accounting firm of the
Company), addressed to the Co-Placement Agents, dated as of the date hereof, in form and substance satisfactory to the Co-Placement Agents.
The letter shall not disclose any change in the condition (financial or other), earnings, operations, business or prospects of the Company
from that set forth in the Incorporated Documents or the applicable Prospectus or prospectus supplement, which, in the Co-Placement Agents&rsquo;
sole judgment, is material and adverse and that makes it, in the Co-Placement Agents&rsquo; sole judgment, impracticable or inadvisable
to proceed with the Offering of the Securities as contemplated by such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Compliance with Registration Requirements; No Stop Order; No Objection from the FINRA.</U> Each Prospectus (in accordance with Rule
424(b)) and &ldquo;<U>free writing prospectus</U>&rdquo; (as defined in Rule 405 of the Securities Act), if any, shall have been duly
filed with the Commission, as appropriate; no stop order suspending the effectiveness of the Registration Statement or any part thereof
shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no order preventing
or suspending the use of any Prospectus shall have been issued and no proceeding for that purpose shall have been initiated or threatened
by the Commission; no order having the effect of ceasing or suspending the distribution of the Securities or any other securities of
the Company shall have been issued by any securities commission, securities regulatory authority or stock exchange and no proceedings
for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company, contemplated by any securities commission,
securities regulatory authority or stock exchange; all requests for additional information on the part of the Commission shall have been
complied with; and the FINRA shall have raised no objection to the fairness and reasonableness of the placement terms and arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Corporate Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement
and each Prospectus, and the registration, sale and delivery of the Securities, shall have been completed or resolved in a manner reasonably
satisfactory to the Co-Placement Agents&rsquo; counsel, and such counsel shall have been furnished with such papers and information as
it may reasonably have requested to enable such counsel to pass upon the matters referred to in this Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Material Adverse Effect</U>. Subsequent to the execution and delivery of this Agreement and prior to each Closing Date, in the
Co-Placement Agents&rsquo; sole judgment after consultation with the Company, there shall not have occurred any Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Opinions of Counsel for the Company</U>. The Co-Placement Agents shall have received on each Closing Date the favorable opinion of
US legal counsel to the Company, dated as of such Closing Date, including, without limitation, a negative assurance letter addressed
to the Co-Placement Agents and in form and substance satisfactory to the Co-Placement Agents and the favorable opinion of intellectual
property legal counsel to the Company, including, without limitation, a negative assurance letter, addressed to the Co-Placement Agents
and in form and substance satisfactory to the Co-Placement Agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Officers&rsquo; Certificate</U>. The Co-Placement Agents shall have received on each Closing Date a certificate of the Company, dated
as of such Closing Date, signed by the Chief Executive Officer and Chief Financial Officer of the Company, to the effect that, and the
Co-Placement Agents shall be satisfied that, the signers of such certificate have reviewed the Registration Statement, the Incorporated
Documents, any Prospectus Supplement, and this Agreement and to the further effect that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The representations and warranties of the Company in this Agreement are true and correct, as if made on and as of such Closing Date,
and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or
prior to such Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
No stop order suspending the effectiveness of the Registration Statement or the use of any Prospectus has been issued and no proceedings
for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no order
having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company has been issued
by any securities commission, securities regulatory authority or stock exchange in the United States and no proceedings for that purpose
have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange in the United States;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
When the Registration Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such
certificate, the Registration Statement and the Incorporated Documents, if any, when such documents became effective or were filed with
the Commission, and any Prospectus, contained all material information required to be included therein by the Securities Act and the
Exchange Act and the applicable rules and regulations of the Commission thereunder, as the case may be, and in all material respects
conformed to the requirements of the Securities Act and the Exchange Act and the applicable rules and regulations of the Commission thereunder,
as the case may be, and the Registration Statement and the Incorporated Documents, if any, and any Prospectus, did not and do not include
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading (provided, however, that the preceding representations
and warranties contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity
with information furnished in writing to the Company by the Placement Agent expressly for use therein) and, since the effective date
of the Registration Statement, there has occurred no event required by the Securities Act and the rules and regulations of the Commission
thereunder to be set forth in the Incorporated Documents which has not been so set forth; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Subsequent to the respective dates as of which information is given in the Registration Statement, the Incorporated Documents and any
Prospectus, there has not been: (a) any Material Adverse Effect; (b) any transaction that is material to the Company and the Subsidiaries
taken as a whole, except transactions entered into in the ordinary course of business; (c) any obligation, direct or contingent, that
is material to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred
in the ordinary course of business; (d) any material change in the capital stock (except changes thereto resulting from the exercise
of outstanding stock options or warrants) or outstanding indebtedness of the Company or any Subsidiary; (e) any dividend or distribution
of any kind declared, paid or made on the capital stock of the Company; or (f) any loss or damage (whether or not insured) to the property
of the Company or any Subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Bring-down Comfort Letter</U>. On each Closing Date, the Co-Placement Agents shall have received from Marcum LLP, or such other independent
registered public accounting firm of the Company, a letter dated as of such Closing Date, in form and substance satisfactory to the Co-Placement
Agents, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (a) of this Section 5, except
that the specified date referred to therein for the carrying out of procedures shall be no more than two (2) business days prior to such
Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Lock-Up Agreements</U>. On the date hereof, the Co-Placement Agents shall have received the executed lock-up agreement, in the form
attached as <U>Exhibit C</U> in the Purchase Agreement, from each of the directors and officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Stock Exchange Listing</U>. The Common Stock shall be registered under the Exchange Act and shall be listed on the Trading Market,
and the Company shall not have taken any action designed to terminate, or likely to have the effect of terminating, the registration
of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market, nor shall
the Company have received any information suggesting that the Commission or the Trading Market is contemplating terminating such registration
or listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Additional Documents</U>. On or before each Closing Date, the Co-Placement Agents and counsel for the Co-Placement Agents shall have
received such information and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and
sale of the Securities as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or
the satisfaction of any of the conditions or agreements, herein contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any condition specified in this Section 5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by
the Co-Placement Agents by notice to the Company at any time on or prior to a Closing Date, which termination shall be without liability
on the part of any party to any other party, except that Section 6 (Payment of Expenses), Section 7 (Indemnification and Contribution)
and Section 8 (Representations and Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6. Payment of Expenses</B>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance
of its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses
incident to the issuance, delivery and qualification of the Securities (including all printing and engraving costs); (ii) all fees and
expenses of the registrar and transfer agent of the Common Stock; (iii) all necessary issue, transfer and other stamp taxes in connection
with the issuance and sale of the Securities; (iv) all fees and expenses of the Company&rsquo;s counsel, independent public or certified
public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing, shipping
and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts),
the Base Prospectus, the Final Prospectus and each Prospectus Supplement, and all amendments and supplements thereto, and this Agreement;
(vi) all filing fees, reasonable attorneys&rsquo; fees and expenses incurred by the Company or the Co-Placement Agents in connection
with qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Securities
for offer and sale under the state securities or blue sky laws or the securities laws of any other country, and, if requested by the
Co-Placement Agents, preparing and printing a &ldquo;<U>Blue Sky Survey</U>,&rdquo; an &ldquo;<U>International Blue Sky Survey</U>&rdquo;
or other memorandum, and any supplements thereto, advising the Co-Placement Agents of such qualifications, registrations and exemptions;
(vii) if applicable, the filing fees incident to the review and approval by the FINRA of the Co-Placement Agents&rsquo; participation
in the offering and distribution of the Securities; (viii) the fees and expenses associated with including the Shares and Warrant Shares
(as defined in the Purchase Agreement) on the Trading Market; (ix) all costs and expenses incident to the travel and accommodation of
the Company&rsquo;s and the Co-Placement Agents&rsquo; employees on the &ldquo;<U>roadshow</U>,&rdquo; if any; and (x) all other fees,
costs and expenses referred to in Part II of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7. Indemnification and Contribution</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company agrees to indemnify and hold harmless the Co-Placement Agents, its respective affiliates and each person controlling the
Co-Placement Agents (within the meaning of Section 15 of the Securities Act), and the directors, officers, agents and employees of the
Co-Placement Agents, its respective affiliates and each such controlling person (the Co-Placement Agents, and each such entity or person.
an &ldquo;<U>Indemnified Person</U>&rdquo;) from and against any losses, claims, damages, judgments, assessments, costs and other liabilities
(collectively, the &ldquo;<U>Liabilities</U>&rdquo;), and shall reimburse each Indemnified Person for all fees and expenses (including
the reasonable fees and expenses of one counsel for all Indemnified Persons, except as otherwise expressly provided herein) (collectively,
the &ldquo;<U>Expenses</U>&rdquo;) as they are incurred by an Indemnified Person in investigating, preparing, pursuing or defending any
Actions, whether or not any Indemnified Person is a party thereto, (i) caused by, or arising out of or in connection with, any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement, any Incorporated Document, or any Prospectus
or by any omission or alleged omission to state therein a material fact necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading (other than untrue statements or alleged untrue statements in, or omissions or alleged omissions
from, information relating to an Indemnified Person furnished in writing by or on behalf of such Indemnified Person expressly for use
in the Incorporated Documents) or (ii) otherwise arising out of or in connection with advice or services rendered or to be rendered by
any Indemnified Person pursuant to this Agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or
inactions in connection with any such advice, services or transactions; <U>provided, however</U>, that, in the case of clause (ii) only,
the Company shall not be responsible for any Liabilities or Expenses of any Indemnified Person that are finally judicially determined
to have resulted solely from such Indemnified Person&rsquo;s (x) gross negligence or willful misconduct in connection with any of the
advice, actions, inactions or services referred to above or (y) use of any offering materials or information concerning the Company in
connection with the offer or sale of the Securities in the Offering which were not authorized for such use by the Company and which use
constitutes gross negligence or willful misconduct. The Company also agrees to reimburse each Indemnified Person for all Expenses as
they are incurred in connection with enforcing such Indemnified Person&rsquo;s rights under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Upon receipt by an Indemnified Person of actual notice of an Action against such Indemnified Person with respect to which indemnity may
be sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure by any Indemnified
Person so to notify the Company shall not relieve the Company from any liability which the Company may have on account of this indemnity
or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by such failure. The Company shall,
if requested by the Co-Placement Agents, assume the defense of any such Action including the employment of counsel reasonably satisfactory
to the Co-Placement Agents, which counsel may also be counsel to the Company. Any Indemnified Person shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and employ counsel or (ii) the named parties
to any such Action (including any impeded parties) include such Indemnified Person and the Company, and such Indemnified Person shall
have been advised in the reasonable opinion of counsel that there is an actual conflict of interest that prevents the counsel selected
by the Company from representing both the Company (or another client of such counsel) and any Indemnified Person; provided that the Company
shall not in such event be responsible hereunder for the fees and expenses of more than one firm of separate counsel for all Indemnified
Persons in connection with any Action or related Actions, in addition to any local counsel. The Company shall not be liable for any settlement
of any Action effected without its written consent (which shall not be unreasonably withheld). In addition, the Company shall not, without
the prior written consent of the Co-Placement Agents (which shall not be unreasonably withheld), settle, compromise or consent to the
entry of any judgment in or otherwise seek to terminate any pending or threatened Action in respect of which indemnification or contribution
may be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise, consent or termination
includes an unconditional release of each Indemnified Person from all Liabilities arising out of such Action for which indemnification
or contribution may be sought hereunder. The indemnification required hereby shall be made by periodic payments of the amount thereof
during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is due and payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
In the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company
shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i) the relative benefits to the Company, on the one hand, and to the Co-Placement Agents and any other Indemnified Person, on the other
hand, of the matters contemplated by this Agreement or (ii) if the allocation provided by the immediately preceding clause is not permitted
by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and the Co-Placement
Agents and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate,
as well as any other relevant equitable considerations; provided that in no event shall the Company contribute less than the amount necessary
to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of
fees actually received by the Co-Placement Agents pursuant to this Agreement. For purposes of this paragraph, the relative benefits to
the Company, on the one hand, and to the Co-Placement Agents on the other hand, of the matters contemplated by this Agreement shall be
deemed to be in the same proportion as (a) the total value paid or contemplated to be paid to or received or contemplated to be received
by the Company in the transaction or transactions that are within the scope of this Agreement, whether or not any such transaction is
consummated, bears to (b) the fees paid to the Co-Placement Agents under this Agreement. Notwithstanding the above, no person guilty
of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act, as amended, shall be entitled to contribution
from a party who was not guilty of fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services
or transactions except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted
solely from such Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with any such advice, actions, inactions
or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services
under or in connection with, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8. Representations and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other
statements of the Company or any person controlling the Company, of its officers, and of the Co-Placement Agents set forth in or made
pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Co-Placement
Agents, the Company, or any of its or their partners, officers or directors or any controlling person, as the case may be, and will survive
delivery of and payment for the Securities sold hereunder and any termination of this Agreement. A successor to the Co-Placement Agents,
or to the Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity,
contribution and reimbursement agreements contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9. Notices</B>. All communications hereunder shall be in writing and shall be mailed, hand delivered or e-mailed and confirmed to the
parties hereto as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Roth to the address set forth above, attention: Aaron Gurewitz, email: ecm@roth.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Laidlaw to the address set forth above, attention: Hugh Regan, email: hregan@laidlawltd.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy to</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ellenoff
Grossman &amp; Schole LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1345
Avenue of the Americas, 11th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10105</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
capmkts@egsllp.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
Air, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">900
Stewart Avenue, Suite 301</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garden
City, NY 11530</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
dlarson@beyondair.net</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Doug Larson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy to</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
Ross Ference Carmel LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
Avenue of the Americas, 31st floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
gsichenzia@srfc.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Greg Sichenzia</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
party hereto may change the address for receipt of communications by giving written notice to the others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10. Successors</B>. This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees,
officers and directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal representative,
and no other person will have any right or obligation hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
11. Partial Unenforceability</B>. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not
affect the validity or enforceability of any other section, paragraph or provision hereof. If any section, paragraph or provision of
this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and
only such minor changes) as are necessary to make it valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
12. Governing Law Provisions</B>. This Agreement shall be deemed to have been made and delivered in New York City and both this Agreement
and the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in all other respects
by the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Each of the Co-Placement Agents
and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating to this Agreement and/or the transactions
contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the United States District Court
for the Southern District of New York, (ii) waives any objection which it may have or hereafter to the venue of any such suit, action
or proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New York, and the United States
District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Co-Placement Agents and the
Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding
in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York and agrees
that service of process upon the Company mailed by certified mail to the Company&rsquo;s address shall be deemed in every respect effective
service of process upon the Company, in any such suit, action or proceeding, and service of process upon the Co-Placement Agents mailed
by certified mail to the respective Placement Agent&rsquo;s address shall be deemed in every respect effective service process upon the
respective Placement Agent, in any such suit, action or proceeding. Notwithstanding any provision of this Agreement to the contrary,
the Company agrees that neither the Co-Placement Agents nor its affiliates, and the respective officers, directors, employees, agents
and representatives of the Co-Placement Agents, its respective affiliates and each other person, if any, controlling the Co-Placement
Agents or any of its respective affiliates, shall have any liability (whether direct or indirect, in contract or tort or otherwise) to
the Company for or in connection with the engagement and transaction described herein except for any such liability for losses, claims,
damages or liabilities incurred by us that are finally judicially determined to have resulted from the willful misconduct or gross negligence
of such individuals or entities. If either party shall commence an action or proceeding to enforce any provision of this Agreement, then
the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable attorney&rsquo;s fees and
other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
13. General Provisions</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof. Notwithstanding anything herein to the contrary,
the Engagement Agreement shall continue to be effective and the terms, including but not limited to Section 5, therein shall continue
to survive and be enforceable by the Co-Placement Agents in accordance with its terms, provided that, in the event of a conflict between
the terms of the Engagement Agreement and this Agreement, the terms of this Agreement shall prevail. This Agreement may be executed in
two or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon
the same instrument. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein
(express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. Section headings herein
are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company acknowledges that in connection with the offering of the Securities: (i) the Co-Placement Agents have acted at arms length,
are not agents of, and owe no fiduciary duties to the Company or any other person, (ii) the Co-Placement Agents owe the Company only
those duties and obligations set forth in this Agreement and (iii) the Co-Placement Agents may have interests that differ from those
of the Company. The Company waives to the full extent permitted by applicable law any claims it may have against the Co-Placement Agents
arising from an alleged breach of fiduciary duty in connection with the offering of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The
remainder of this page has been intentionally left blank.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing is in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all
counterparts hereof, shall become a binding agreement in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours, </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BEYOND
    AIR, INC., </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    Delaware corporation</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing Placement Agency Agreement is hereby confirmed and accepted as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ROTH
    CAPITAL PARTNERS, LLC</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAIDLAW
    &amp; COMPANY (UK), LTD.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>BEYOND
AIR, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: March 22, 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on March 22, 2027
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Beyond Air, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), up to shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common
Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section
2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-3 (File No. 333-262311).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Securities Transfer Corporation, the current transfer agent of the Company, with a mailing address of 2901 N Dallas
Parkway, Suite 380, Plano, Texas 75093 and an email address of info@stctransfer.com, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $2.25, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may only be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
    as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice
    of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the Bid Price of the Common
    Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s
    execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo;
    on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular
    trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of
    Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant
    to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
    the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
    the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if
    such exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
    of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
    Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
    Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in
    such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
    of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery
    of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
    Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
    by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one
    (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the
    Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
    Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the
    holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
    of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received
    within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following
    delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a
    Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
    as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the
    applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant
    Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder
    rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this
    Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement
    period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as
    in effect on the date of delivery of the Notice of Exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such
notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Call Provision</U>. Subject to the provisions of Section 2(e) and this Section 2(f), if (i) the Company publicly reports at least
$4,500,000 in ordinary course net sales of Lungfit products for the quarter ending March 31, 2025 in the filing of its Annual Report
on Form 10-K with the Commission (such date the Company files its Annual Report on Form 10-K, the &ldquo;<U>Reporting Date</U>&rdquo;),
and (ii) the Holder is not in possession of any information that constitutes, or might constitute, material non-public information which
was provided by the Company, any of its Subsidiaries, or any of their officers, directors, employees, agents or Affiliates, then the
Company may, within 1 Trading Day of the Reporting Date, call for cancellation of all or any portion of this Warrant for which a Notice
of Exercise has not yet been delivered (such right, a &ldquo;<U>Call</U>&rdquo;) for consideration equal to $0.001 per Warrant Share.
To exercise this right, the Company must deliver to the Holder an irrevocable written notice (a &ldquo;<U>Call Notice</U>&rdquo;), indicating
therein the portion of unexercised portion of this Warrant to which such notice applies. If the conditions set forth below for such Call
are satisfied from the period from the date of the Call Notice through and including the Call Date (as defined below), then any portion
of this Warrant subject to such Call Notice for which a Notice of Exercise shall not have been received by the Call Date will be cancelled
at 6:30 p.m. (New York City time) on the tenth (10<SUP>th</SUP>) Trading Day after the date the Call Notice is received by the Holder
(such date and time, the &ldquo;<U>Call Date</U>&rdquo;). Any unexercised portion of this Warrant to which the Call Notice does not pertain
will be unaffected by such Call Notice. In furtherance thereof, the Company covenants and agrees that it will honor all Notices of Exercise
with respect to Warrant Shares subject to a Call Notice that are tendered through 6:30 p.m. (New York City time) on the Call Date. The
parties agree that any Notice of Exercise delivered following a Call Notice which calls less than all of the Warrants shall first reduce
to zero the number of Warrant Shares subject to such Call Notice prior to reducing the remaining Warrant Shares available for purchase
under this Warrant. For example, if (A) this Warrant then permits the Holder to acquire 100 Warrant Shares, (B) a Call Notice pertains
to 75 Warrant Shares, and (C) prior to 6:30 p.m. (New York City time) on the Call Date the Holder tenders a Notice of Exercise in respect
of 50 Warrant Shares, then (x) on the Call Date the right under this Warrant to acquire 25 Warrant Shares will be automatically cancelled,
(y) the Company, in the time and manner required under this Warrant, will have issued and delivered to the Holder 50 Warrant Shares in
respect of the exercises following receipt of the Call Notice, and (z) the Holder may, until the Termination Date, exercise this Warrant
for 25 Warrant Shares (subject to adjustment as herein provided and subject to subsequent Call Notices). Notwithstanding anything to
the contrary set forth in this Warrant, the Company may not deliver a Call Notice or require the cancellation of this Warrant (and any
such Call Notice shall be void), unless, from the Reporting Date through the Call Date, (1) the Company shall have honored in accordance
with the terms of this Warrant all Notices of Exercise delivered by 6:30 p.m. (New York City time) on the Call Date, and (2) a registration
statement shall be effective as to all Warrant Shares and the prospectus thereunder available for use by the Company for the sale of
all such Warrant Shares to the Holder, and (3) the Common Stock shall be listed or quoted for trading on the Trading Market, and (4)
there is a sufficient number of authorized shares of Common Stock for issuance of all Warrant Shares, and (5) the issuance of all Warrant
Shares subject to a Call Notice shall not cause a breach of any provision of Section 2(e) herein, and (6) there shall be no uncured default
by the Company under any of the Transaction Documents. The Company&rsquo;s right to call the Warrants under this Section 2(f) shall be
exercised ratably among the Holders based on each Holder&rsquo;s initial purchase of Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that
the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the
Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless
of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a
Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board
of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service, addressed to the Company, at 900 Stewart Avenue, Garden City, New York 11530, Attention: Adam T. Newman, email address:
anewman@beyondair.net, or such other email address or address as the Company may specify for such purposes by notice to the Holders.
Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,
by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of
such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and
effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address
set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission,
if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading
Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent
by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to
be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
Holders of at least 67% of the then outstanding Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>BEYOND
    AIR, INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B></B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">beyond
    air, inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 7%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Phone
    Number:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email
    Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:_______________________<U></U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address:________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
22, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
Air, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">900
Stewart Avenue, Suite 301</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garden
City, NY 11530</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering
    of Shares and Warrants</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Beyond Air, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the issuance and sale
by the Company of (i) 9,638,556 shares of common stock (the &ldquo;Shares&rdquo;) of the Company&rsquo;s common stock, $0.0001 par value
per share (the &ldquo;Common Stock&rdquo;) and (ii) warrants (the &ldquo;Warrants&rdquo;) to purchase up to 9,638,556 shares of Common
Stock (the &ldquo;Warrant Shares&rdquo;), pursuant to the Securities Purchase Agreement (the &ldquo;Securities Purchase Agreement&rdquo;),
dated March 20, 2024, between the Company and the purchasers identified on the signature pages thereto (the &ldquo;Purchasers&rdquo;)
and the Placement Agency Agreement (the &ldquo;Placement Agency Agreement&rdquo;), dated March 20, 2024, between the Company, Roth Capital
Partners, LLC and Laidlaw &amp; Company (UK) Ltd. (the &ldquo;Co-Placement Agents&rdquo;). Capitalized terms used herein but otherwise
defined shall have the meaning set forth in the Securities Purchase Agreement. The Shares, Warrants and Warrant Shares shall be hereinafter
collectively referred as the &ldquo;Securities.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities were sold by the Company pursuant to a prospectus supplement dated March 20, 2024 (the &ldquo;Prospectus Supplement&rdquo;)
and the accompanying base prospectus, dated February 1, 2022 (together with the Prospectus Supplement, the &ldquo;Prospectus&rdquo;),
that form part of the Company&rsquo;s registration statement on Form S-3 (File No. 333-262311) filed with the Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) on January 24, 2022 (the &ldquo;Registration Statement&rdquo;), and declared effective on February
1, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon, subject to, and limited by the foregoing, we are of the opinion that as of the date hereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
                                            the (i) execution and delivery by the Company of the Securities Purchase Agreement, (ii)
                                            issuance of the Shares pursuant to the terms of the Securities Purchase Agreement and the
                                            due registration on the books of the transfer agent and registrar therefor, (iii) receipt
                                            by the Company of the consideration for the Shares in the circumstances contemplated by the
                                            Securities Purchase Agreement, the Shares will be validly issued, fully paid, and nonassessable.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            the Warrants shall have been duly registered on the records maintained by the Company for
                                            that purpose in the name or on behalf of the purchaser and have been issued by the Company
                                            against payment therefor in the circumstances contemplated by the Agreement, the Warrants
                                            will constitute the legal, valid and binding obligations of the Company, enforceable against
                                            the Company in accordance with their terms.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
                                            the Warrant Shares issuable upon exercise of the Warrants shall have been duly registered
                                            on the books of the transfer agent and registrar therefor in the name of or on behalf of
                                            the Warrant holders and have been issued by the Company against payment therefor (not less
                                            than par value) in the circumstances contemplated by the Warrants, the Warrant Shares will
                                            be validly issued, fully paid, and nonassessable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
opinion in numbered paragraphs 2 is subject to: (i) the effect of bankruptcy, insolvency, reorganization, fraudulent transfer, moratorium,
or other similar laws relating to or affecting the rights and remedies of creditors; (ii) the effect of general principles of equity,
whether considered in a proceeding in equity or at law (including the possible unavailability of specific performance or injunctive relief),
concepts of materiality, reasonableness, good faith, and fair dealing, and the discretion of the court before which a proceeding is brought;
(iii) we express no opinion as to (a) any provision for liquidated damages, monetary penalties, or other economic remedies to the extent
such provisions are deemed to constitute a penalty, (b) consents to, or restrictions upon, governing law, jurisdiction, venue, arbitration,
remedies, or judicial relief, (c) waivers of rights or defenses, (d) any provision requiring the payment of attorneys&rsquo; fees, where
such payment is contrary to law or public policy, (e) advance waivers of claims, defenses, rights granted by law, or notice, opportunity
for hearing, evidentiary requirements, statutes of limitation, trial by jury, or at law, or other procedural rights, (f) waivers of broadly
or vaguely stated rights, (g) provisions for exclusivity, election, or cumulation of rights or remedies, (h) provisions authorizing or
validating conclusive or discretionary determinations, (i) proxies, powers, and trusts, (j) provisions prohibiting, restricting, or requiring
consent to assignment or transfer of any right or property, and (k) the severability, if invalid, of provisions to the foregoing effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our opinion, we have examined such matters of fact as we have deemed necessary, which included examination of originals
or copies, certified or otherwise identified to our satisfaction of: (i) the Registration Statement, (ii) the Prospectus, (iii) the Transaction
Documents, (iv) the Certificate of Incorporation of the Company, as amended, (v) the Amended and Restated Bylaws of the Company, as currently
in effect, and (vi) certain resolutions of the Board of Directors of the Company and the filing of the Registration Statement and Prospectus.
We also examined originals or copies, certified or otherwise identified to our satisfaction, of such records of the Company and such
agreements, certificates, and receipts of public officials, certificates, of officers or other representatives of the Company and others,
and such other documents, certificates, and records as we have deemed necessary or appropriate as a basis for the opinions set forth
below. We have also examined such questions of law as we considered necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our examination of documents for purposes of this opinion, we have assumed, and express no opinion as to, the genuineness of all signatures,
the legal capacity of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to original
documents of all documents submitted to us as certified, conformed, or photostatic copies, and the authenticity of the originals of such
latter documents. As to all questions of fact material to this opinion that have not been independently established, we have relied upon
certificates or comparable documents of officers and representatives of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
express no opinion herein as to the laws of any state or jurisdiction other than the Delaware General Corporate Law (including the statutory
provisions and all applicable judicial decisions interpreting those laws), the federal laws of the United States of America, and, with
respect to our opinion in relating to the enforceability of the Warrants, the laws of the State of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have assumed (a) that the Warrants have been or will be duly authorized, executed, and delivered by the parties thereto other than the
Company, (b) that such securities constitute or will constitute legally valid and binding obligations of the parties thereto other than
the Company, enforceable against each of them in accordance with their respective terms, and (c) that the status of the Warrants as legally
valid and binding obligations of the parties will not be affected by any (i) breaches of, or defaults under, agreements, or instruments,
(ii) violations of statutes, rules, regulations, or court or governmental orders, or (iii) failures to obtain required consents, approvals,
or authorizations from, or to make required registrations, declarations, or filings with, governmental authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter has been prepared for use in connection with the filing by the Company of a Current Report on Form 8-K relating to the
offer and sale of the Securities, which Form 8-K will be incorporated by reference into the Registration Statement and Prospectus and
speaks as of the date hereof. We assume no obligation to advise you of any fact, circumstance, event, or change in the law or the facts
that may hereafter be brought to our attention, whether or not such occurrence would affect or modify any of the opinions expressed herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion letter as Exhibit 5.1 to the above-described Form 8-K and to the reference to this firm
under the caption &ldquo;Legal Matters&rdquo; in the Prospectus. In giving this consent, we do not thereby admit that we are an &ldquo;expert&rdquo;
within the meaning of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><I>/s/
                                            Sichenzia Ross Ference Carmel LLP</I></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: right; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of ______, 2024, between Beyond Air, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2<SUP>nd</SUP>)
Trading Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrant</U>&rdquo; means, collectively, the Common Stock purchase warrants to be delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Common Warrant shall be exercisable immediately upon issuance and have a term equal to three (3) years,
in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Sichenzia Ross Ference Carmel LLP, with offices located at 1185 6<SUP>th</SUP> Ave, 31<SUP>st</SUP> Floor, New
York, NY 10036.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EGS</U>&rdquo;
means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities
upon the exercise or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible
into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended
since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion
price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, and (c)
securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company,
provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights
that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 4.11(a)
herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and officers
of the Company, in the form of <U>Exhibit C</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $_____, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per
Prefunded Warrant shall be the Per Share Purchase Price minus $0.0001.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Roth Capital Partners, LLC and Laidlaw &amp; Company (UK) Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prefunded
Warrant</U>&rdquo; means, collectively, the Prefunded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full, in the
form of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prefunded
Warrant Shares</U>&rdquo; means the Common Stock issuable upon exercise of the Prefunded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the base prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the
Commission and delivered by the Company to each Purchaser at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No. 333-262311 which registers the sale of the Shares,
the Warrants and the Warrant Shares to the Purchasers, and includes any Rule 462(b) Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
462(b) Registration Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Securities,
which was filed with the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated
by the Commission pursuant to the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the
Prefunded Warrants, which amounts shall be paid as and when such Prefunded Warrants are exercised).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Lock-Up Agreement, the Warrants, all exhibits and schedules thereto and hereto and any
other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Securities Transfer Corporation, the current transfer agent of the Company, with a mailing address of 2901 N.
Dallas Parkway<BR>
Suite 380, Plano, Texas 75093 and an email address of info@stctransfer.com, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.11(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Prefunded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE
AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the
Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $_______ of Shares and Common Warrants; <U>provided</U>,
<U>howeve</U>r, that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s
Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially
own in excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares such Purchaser
may elect to purchase Prefunded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price being paid by
such Purchaser to the Company. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, at the election of the Purchaser
at Closing, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities
on the Closing Date. Each Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser
shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company or its designee. The Company shall deliver
to each Purchaser its respective Shares and Warrants as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall
deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth
in Sections 2.2 and 2.3, the Closing shall occur at the offices of EGS or such other location as the parties shall mutually agree take
place remotely by electronic transfer of the Closing documentation. Unless otherwise directed by the Placement Agent, settlement of the
Shares shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) (i.e., on the Closing Date, the Company shall
issue the Shares registered in the Purchasers&rsquo; names and addresses and released by the Transfer Agent directly to the account(s)
at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent shall promptly electronically deliver
such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer
to the Company). Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of this Agreement
by the Company and an applicable Purchaser, through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement
Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of the Shares to be issued hereunder to such Purchaser at
the Closing (collectively, the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any
additional required actions by such Purchaser or the Company), be deemed to be unconditionally bound to purchase, such Pre-Settlement
Shares at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such Purchaser prior
to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement Shares hereunder; and provided further that the Company hereby
acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to whether or not during
the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person and that any such decision to sell any shares
of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects to effect any such sale, if any. Notwithstanding
anything to the contrary herein and a Purchaser&rsquo;s Subscription Amount set forth on the signature pages attached hereto, the number
of Shares purchased by a Purchaser (and its Affiliates) hereunder shall not, when aggregated with all other shares of Common Stock owned
by such Purchaser (and its Affiliates) at such time, result in such Purchaser beneficially owning (as determined in accordance with Section
13(d) of the Exchange Act) in excess of such Purchaser&rsquo;s Beneficial Ownership Limitation of the then issued and outstanding Common
Stock outstanding at the Closing (the &ldquo;<U>Beneficial Ownership Maximum</U>&rdquo;), and such Purchaser&rsquo;s Subscription Amount,
to the extent it would otherwise exceed the Beneficial Ownership Maximum immediately prior to the Closing, shall be conditioned upon
the issuance of Shares at the Closing to the other Purchasers signatory hereto. To the extent that a Purchaser&rsquo;s beneficial ownership
of the Shares would otherwise be deemed to exceed the Beneficial Ownership Maximum, such Purchaser&rsquo;s Subscription Amount shall
automatically be reduced as necessary in order to comply with this paragraph. Notwithstanding the foregoing, with respect to any Notice(s)
of Exercise (as defined in the Prefunded Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Closing Date, which
may be delivered at any time after the time of execution of this Agreement, the Company agrees to deliver the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date
(as defined in the Prefunded Warrants) for purposes hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">(a)
On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the
following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel, in form and substance reasonably acceptable to the Placement Agent and Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The
Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) Shares equal to such Purchaser&rsquo;s
Subscription Amount divided by the Per Share Purchase Price (minus the number of shares of Common Stock issuable upon exercise of such
Purchaser&rsquo;s Prefunded Warrants, if applicable), registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of the sum
of such Purchaser&rsquo;s Shares and Prefunded Warrants, if any, with an exercise price equal to $____, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
for each Purchaser of Prefunded Warrants pursuant to Section 2.1, a Prefunded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Prefunded Warrant
divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal to $0.0001, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
on the date hereof, the duly executed Lock-Up Agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
the duly executed and delivered Officers&rsquo; Certificate, in form and substance reasonably acceptable to the Placement Agent and Purchasers;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount (less the aggregate exercise price of the Prefunded Warrants issuable to such Purchaser hereunder,
if applicable), which shall be made available for DVP settlement with the Company or its designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in
which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, nor shall there have occurred a national or global pandemic, or any material adverse change in, any financial
market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities
at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the
corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. Except as set forth
in <U>Schedule 3.1(a)</U>, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary
free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has
no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. Except as set forth in <U>Schedule 3.1(d)</U>, the execution, delivery and performance by the Company of this Agreement
and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the
transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or
any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict
with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation
of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment,
anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the
Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)
subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal
and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except
in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s)
to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required
thereby, and (iv) such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required
Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with
the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed
by the Company. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and
nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the
maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the
Registration Statement in conformity with the requirements of the Securities Act, which became effective on February 1, 2022 (the &ldquo;<U>Effective
Date</U>&rdquo;), including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this
Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness
of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings
for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required
by the rules and regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant to Rule 424(b). At
the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date,
the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the
Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary to make the statements therein not misleading; and the Prospectus and the Prospectus Supplement and any
amendments or supplements thereto, at the time the Prospectus and the Prospectus Supplement or any amendment or supplement thereto was
issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did
not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the
Registration Statement eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities Act and it meets the transaction
requirements as set forth in General Instruction I.B.1 of Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule
3.1(g)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as
of the date hereof. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act,
other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of
Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise
of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. Except as set
forth on <U>Schedule 3.1(g)</U>, no Person has any right of first refusal, preemptive right, right of participation, or any similar right
to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities
and set forth on <U>Schedule 3.1(g)</U>, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or
giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares
of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate
the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). Except as
set forth on <U>Schedule 3.1(g)</U>, there are no outstanding securities or instruments of the Company or any Subsidiary with any provision
that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company
or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or
similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is
or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or
&ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the
Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state
securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe
for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect
to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the
Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and
the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received
a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in
accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result
in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables
and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be
reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company
has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property
to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company
has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The
Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of
the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists
or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects,
properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities
laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the
date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i)
adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii)
could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company
nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or
liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of
the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former
director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters which could reasonably be expected to result in a Material Adverse Effect. The Company and
its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment
practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None
of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights
has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date
of this Agreement except where such expiration, termination or abandonment would not reasonably be expected to have a Material Adverse
Effect. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within
the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge
of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any
of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that
it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions With Affiliates and Employees</U>. None of the officers or directors of the Company or any Subsidiary and, to the knowledge
of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any
Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing
for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of
money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge
of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for
services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock
option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002, as amended that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and
designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it
files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s
rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of
the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act
(such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as
such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely
to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Registration Rights</U>. Except as set forth on <U>Schedule 3.1(v)</U>, no Person has any right to cause the Company or any Subsidiary
to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which
the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer
through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to
the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise
disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation
in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers
regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure
Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U> sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For
the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess
of $100,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other
contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $100,000 due
under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Accountants</U>. The Company&rsquo;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company,
such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with
respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending March 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities
(if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any
of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>FDA</U>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under
the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured,
packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical
Product</U>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed
by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration,
investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices,
good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure
to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company&rsquo;s knowledge, threatened,
action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation)
against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter
or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration,
or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and
promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical
hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company
or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of
its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries,
and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of
the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations
of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United
States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving
or clearing for marketing any product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Cybersecurity</U>. (i)(x) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any
Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective
customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of
any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and
Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders,
rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use,
access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii)
the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material
confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company
and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years
were, in compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including, without
limitation, the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;) (EU 2016/679) (collectively, &ldquo;<U>Privacy
Laws</U>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to
ensure compliance with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure,
handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); (iii) the Company provides accurate notice
of its applicable Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and
(iv) applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its
subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy
Laws. &ldquo;<U>Personal Data</U>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph,
social security number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally
identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR;
and (iv) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection
or analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures
made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the
execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither
the Company nor the Subsidiaries (i) to the knowledge of the Company, has received written notice of any actual or potential liability
of the Company or the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy
Laws; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant
to any regulatory request or demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any
court or arbitrator or governmental or regulatory authority that imposed any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the
ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Warrants, it will be an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3),
(a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the
Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to
such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received details regarding this transaction from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Warrant Shares</U>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to
cover the issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant
to any such exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or any
subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available
for the sale or resale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration
statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again
and available for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability
of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal and state securities
laws). The Company shall use best efforts to keep a registration statement (including the Registration Statement) registering the issuance
or resale of the Warrant Shares effective during the term of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information</U>. Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired,
the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports
required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the
reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including,
without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the
prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission
and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers
with prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of
their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade
on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. Except as set forth in the Prospectus Supplement, the Company shall use the net proceeds from the sale of the
Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s
debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption
of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or
OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;Purchaser Party&rdquo;) harmless from any and all
losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements,
court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result
of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the
transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s
representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may
have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser
Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct. If any action shall be brought
against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly
notify the Company in writing, and, the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent
that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel a
material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be
liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior
written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim,
damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements
made by such Purchaser Party in this Agreement or in any other Transaction Documents. The indemnification required by this Section 4.8
shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock
on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all
of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such
Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will
then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of
the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take
all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects
with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees
to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing
corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing
corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii)
file any registration statement or amendment or supplement thereto, other than the Prospectus Supplement or filing a registration statement
on Form S-8 in connection with any employee benefit plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until the six (6) month anniversary of the Closing Date, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other
price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the
initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset
at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events
directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction
under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined
price regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently
canceled; provided, however, that sales under the Company&rsquo;s existing at-the-market offering sales agreement shall be permitted
ninety (90) days after the Closing Date and shall not be deemed a Variable Rate Transaction. Any Purchaser shall be entitled to obtain
injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included
in the Disclosure Schedules (other than as disclosed to its legal and other representatives). Notwithstanding the foregoing and notwithstanding
anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation,
warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance
with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty
not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors,
employees, Affiliates, or agent, including, without limitation, the Placement Agent, after the issuance of the initial press release
as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge
of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set
forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Capital Changes</U>. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock
split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the
Shares and Prefunded Warrants other than a reverse stock split that is required, in the good faith determination of the Board of Directors,
to maintain the listing of the Common Stock on the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms,
conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If
any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek
specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if
sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Prefunded
Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case
of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification
or waiver disproportionately and adversely impacts a Purchaser (or multiple Purchasers), the consent of such disproportionately impacted
Purchaser (or at least 50.1% in interest of such multiple Purchasers) shall also be required. No waiver of any default with respect to
any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any
subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party
to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately,
materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the
other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with
this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations, warranties, and
covenants of the Company in this Agreement and the representations, warranties, and covenants of the Purchasers in this Agreement. This
Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section
5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall
be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through EGS. EGS does not represent any of the Purchasers and only represents the Placement Agent. The Company
has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because
it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in
this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and
the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">BEYOND
    AIR, INC.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
    a copy to (which shall not constitute notice):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">XAIR</FONT> SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: _________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Warrants to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prefunded
Warrant Shares: ___________ Beneficial Ownership Blocker &#9744;  4.99% or &#9744;  9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrant Shares: __________________ Beneficial Ownership Blocker &#9744;  4.99% or &#9744;  9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: ____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beyond
Air&reg; Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
20, 2024 | 9:02 am EST</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GARDEN
CITY, N.Y., March 20, 2024 &mdash; Beyond Air, Inc. (NASDAQ: XAIR) (&ldquo;Beyond Air&rdquo; or the &ldquo;Company&rdquo;), a commercial
stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve
the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer,
Ltd. (&ldquo;Beyond Cancer&rdquo;)), today announced that it has entered into a securities purchase agreement with healthcare focused
institutional investors and accredited investors, including certain directors and officers of the Company, whereby the investors have
agreed to purchase 9,638,556 shares of the Company&rsquo;s common stock and warrants to purchase up to an aggregate of 9,638,556 shares
of common stock at a purchase price of $1.66 per share and accompanying warrant in a registered direct offering priced at-the-market
under Nasdaq rules. The warrants have an exercise price of $2.25 per share, will be exercisable immediately upon issuance and will have
a term of three years following the date of issuance. The Company can call the warrants if it reports equal to or greater than $4.5 million
of net sales for the quarter ending March 31, 2025 which will require exercise within 10 business days. The closing of the offering is
expected to occur on or about March 22, 2024, subject to the satisfaction of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross proceeds to the Company from this offering are expected to be approximately $16.0 million before deducting the placement agent
fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering to fund commercial
sales development, research, working capital, and other general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roth
Capital Partners and Laidlaw &amp; Company (UK) Ltd. acted as co-placement agents for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities in the offering described above are being offered by the Company pursuant to an effective &ldquo;shelf&rdquo; registration
statement on Form S-3 (File No. 333-262311) previously filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;),
which was declared effective on February 1, 2022<B>.</B> The offering is being made only by means of a prospectus, including a prospectus
supplement, forming a part of the effective registration statement, relating to the offering that will be filed with the SEC. Electronic
copies of the final prospectus supplement and accompanying prospectus relating to the registered direct offering may be obtained, when
available, by contacting Roth Capital Partners, LLC 888 San Clemente Drive, Suite 400, Newport Beach, CA 92660, by phone at (800) 678-9147
or Laidlaw &amp; Company (UK) Ltd., 521 Fifth Ave., 12th Floor, New York, NY 10175, Attention: Syndicate Dept., by email: syndicate@laidlawltd.com
or by accessing the SEC&rsquo;s website, <U>www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration
or qualification under the securities laws of any such state or other jurisdiction. Any offers, solicitations or offers to buy, or any
sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Beyond Air&reg;, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
Air is a commercial stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous
nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The
Company has received FDA approval for its first system, LungFit&reg; PH, for the treatment of term and near-term neonates with hypoxic
respiratory failure. Beyond Air is currently advancing its other revolutionary LungFit systems in clinical trials for the treatment of
severe lung infections such as viral community-acquired pneumonia (including COVID-19), and nontuberculous mycobacteria (NTM) among others.
Also, the Company has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment
of autism spectrum disorder (ASD) and other neurological disorders. Additionally, Beyond Cancer, Ltd., an affiliate of Beyond Air, is
investigating ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting.
For more information, visit <U>www.beyondair.net</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward
Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><BR>
This press release contains &ldquo;forward-looking statements&rdquo; concerning the potential safety and efficacy of inhaled nitric oxide
and the ultra-high concentration nitric oxide product candidate, as well as its therapeutic potential in a number of indications; and
the potential impact on patients and anticipated benefits associated with inhaled nitric oxide and the ultra-high concentration nitric
oxide product candidate. Forward-looking statements include statements about expectations, beliefs, or intentions regarding product offerings,
business, results of operations, strategies or prospects. You can identify such forward-looking statements by the words &ldquo;appears,&rdquo;
&ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo;
&ldquo;looks,&rdquo; &ldquo;projects,&rdquo; &ldquo;goal,&rdquo; &ldquo;assumes,&rdquo; &ldquo;targets&rdquo; and similar expressions
and/or the use of future tense or conditional constructions (such as &ldquo;will,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;should&rdquo;
and the like) and by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking
statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking
statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could
cause actual results to differ materially from any future results expressed or implied by the forward-looking statements. These forward-looking
statements are only predictions and reflect views as of the date they are made with respect to future events and financial performance.
Many factors could cause actual activities or results to differ materially from the activities and results anticipated in forward-looking
statements, including those related to the completion of the offering, risks related to the ability to raise additional capital; the
timing and results of future pre-clinical studies and clinical trials; the potential that regulatory authorities, including the FDA and
comparable non-U.S. regulatory authorities, may not grant or may delay approval for our product candidates; the approach to discover
and develop novel drugs, which is unproven and may never lead to efficacious or marketable products; the ability to fund and the results
of further pre-clinical studies and clinical trials of our product candidates; obtaining, maintaining and protecting intellectual property
utilized by products; obtaining regulatory approval for products; competition from others using similar technology and others developing
products for similar uses; dependence on collaborators; and other risks, which may, in part, be identified and described in the &ldquo;Risk
Factors&rdquo; section of Beyond Air&rsquo;s most recent Annual Report on Form 10-K and other of its filings with the Securities and
Exchange Commission, all of which are available on Beyond Air&rsquo;s website. Beyond Air and Beyond Cancer undertake no obligation to
update, and have no policy of updating or revising, these forward-looking statements, except as required by applicable law.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONTACTS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations contacts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Corey Davis, Ph.D.<BR>
LifeSci Advisors, LLC<BR>
<U>Cdavis@lifesciadvisors.com</U><BR>
(212) 915-2577</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !/ +T# 2(  A$! Q$!_\0
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MHEMKA \;CN#7#5HSI:2(::,#XAZ%>^)?!5]I>GB,W,VS8)&VCA@3S^%>'?\
M"C_&7_/*R_\  @5]!^)O$%OX7\/W.L744LL-N%W)'C<<D#O]:\\_X: \/_\
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M1VDH\1SV,MP7_=FS1E4+COGO1.FX;L&K&U11168CS[3?^2@R_P#7:2NXO_\
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0<^]=!7.YM>Z*X4445 C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>xair-20240320.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa2FabP9z5Z8eekhvWB5bSnazysiwBrOqyZQGvq2IdIL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:XAIR="http://beyondair.net/20240320" elementFormDefault="qualified" targetNamespace="http://beyondair.net/20240320">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://beyondair.net/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="xair-20240320_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="xair-20240320_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>xair-20240320_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>xair-20240320_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://beyondair.net/role/Cover" xlink:href="xair-20240320.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://beyondair.net/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M,WS+M"&##9<9YB2T]'V*VC9..M^J2E)<<I8)P\\:'E:.M#1^BEOW6\"A;<%
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M;%!+ 0(4 Q0    ( *F =EB@8;4N[0   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( *F =EB97)PC$ 8  )PG
M   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ J8!V6&EH))AD!   (!$  !@              ("!# @  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( *F =EB?H!OPL0(  .(,
M   -              "  :8,  !X;"]S='EL97,N>&UL4$L! A0#%     @
MJ8!V6)>*NQS     $P(   L              ( !@@\  %]R96QS+RYR96QS
M4$L! A0#%     @ J8!V6*K$(A8S 0  (@(   \              ( !:Q
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *F =E@D'INBK0   /@!   :
M              "  <L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( *F =EAED'F2&0$  ,\#   3              "  ; 2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://beyondair.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>xair-20240320.xsd</File>
    <File>xair-20240320_lab.xml</File>
    <File>xair-20240320_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "XAIR",
   "nsuri": "http://beyondair.net/20240320",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "xair-20240320.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "xair-20240320_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xair-20240320_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://beyondair.net/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://beyondair.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001493152-24-010974-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-010974-xbrl.zip
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M1#-3G!L<"0(I4)@:%>V<6?$L6XY'='>\ ^,9^:T;\I.'F[,D<$B12;BJW3$
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M0<WH?F'GW/D&KG\0]7C_]_ @SC_5S]=>D%_(3'MTCH"83 1'4LK$R+-/&.3
MH,A^']^A%R;@N83<AT"[JVD?74%Z\KA@OM 08TPZAW\[-.F3-P<@V,1;IZRV
M3*ID7B5+]LJ;O#87G+?59L78SZD7M>4#!N)?9#5FI:S@H7?)]%,R]U-&Q,/5
M-W'D6DR_F2"/+=G);OF^)_6M6[@06_%)![F*9O!XA&E7*"V6@::@SDQ8%ZL8
M#Q[(F6=AWZEAP7N&1WV)H_Y;1NU5D;S[1E/?*'D([Q116B5Y"?Y@Z60^H_NC
MSB6)#N8U'NG,41C#[S@C"X91X70%V=E2IFB06P/Y%OOF+#/"_7&L @("[/WQ
M2)3Z>H#E!OA--L-32F$E)A._,=DH76L>,\]LQ@=^"!]0!040TL905%/$!VBO
M4T[1:N"^(S\12_($W;G+B,+N, V86>',"%_%5HH.J'5RI%:V &,\:BN?XE'W
M/OG@EAW.#1VM=+H3S7'!.<UD!#8L5B /:O.U_)S7YN9<G[1R_TGTE@Y^_0.^
M2-R-3Z+_P5I!^'J7T]+*:?&)J60$^^1R">\_KI))-GT2O0$ED$G]ID0"W@_2
M._0I_&:7&[/+C;G9SN$).X>/0;A7E,+M',)7&B/.:(M%/<040G%Y.>N3-;)!
MW\2^1NE1R8;KTCJC6DI@;?U@Z@UMNV5/I8ITG5-(9@E707//>0ZL5:<>L)A\
M7+[CH>UMB"FBF6<2L<-['EY2H2(K%E_=ZT GZTG4K 2N,SA=&//O=9BR9S;-
M.'E<R$3S7Q48&_3K,D Y<C.84;E!%944-2_Y=YT?6'J*6[$)S"AXO#!808 .
ML:8<CQ;))TD+=XJZ_ACG!_N9FR35Q/FN3J/+[NHUG&E-.@/NO.>?32FL1*3F
M6"TYN^3OKT;XD)<Z7C%-/>DU" ;<9!AREB( ]2$'FQH&VYR_^:J]!E-PH\UV
M>TE[F[(;8,V>DK\QI^1_F5E8ZL&> ;;"X-M+V!JT:C"E/N[EAWZ?$OJ/V JY
M9!_2H*"@P#O:?^N.'#(JQW:(MX.ZKM"#L>D9],(241"5H)J.PMAJI31<$LUC
MHS5)BM(7GFM)V[EBM\FUM>[D[K6=5/W;=+5%W:.^M\\'8DU\&5-%EJ<Z+ 6Z
MU[ 47^=KPZE3@3M63="5E4PY:\B<L_>ARBBDW7)RZ9GDV=G@>NPEV^274M="
MG*6Y^13!@I7A_!!?0;C0IJ19G\9XU GMH(.C):<'F>D .=PL:82.:X'&(^]L
M47J7<]_8DJC4,@P':@\;K_B?C%N0S,0CDH1 UOK>YWVM9\*;%,Z[1)B\";0+
M$IWH%E]Q%>U=[CO)&5!":$F#U5@31M?V$DY$F6Y.%LYK%&8H6VI,.PIG/7=?
M< #8E>3M8E([?0<O#*ON7.$M)AX<CT*:NAG!4!T"WSG+]PYHWU/6OBT,R$\B
MQ$4+?^,\.]:A4[@J2F0:3ES#Y 'RDLYFV12+\]"+8R/8DB:JEQ6,MN!CY'Z!
M:8%P5H@Y^])ZZ(4R27O3;%R-W,VM:&4Z^FZW\:C'[_;U>'?'IE>S:2I&(E>B
M_I:P#^D4+ZZIBYIV_(ZA1+;J US;%YCLCJ:8UK82WZ$[!KUZI69 8P[D:K&0
MR]>_:FI.0K>7#5TT05A'];LK/+HNN$!UP/C2I,)TWE7#%<->-KE5_EPB.OUY
MP$4"# ZDF>Q>_:F%-VI-<0 UR*X:AX+?9%97\@G0=]G:+'3&."O\&&S[=J*K
M@Z^-%;K(96^9EJA;.X-!;G<I6O'=Y?[4X?X4VQ^FP4]D79N]560?YLH_+Y,*
MA1CLDTJU5C2X^XLPJ:CJ&Q?4*DQ!/BOSU'2PF(A:)+L\F30@V=[K8HZ76#@
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M2!=/V0?3 TGEH.-",-3]+VOQT$*9UY8/-F+5Z?C0R1<'?8+,%EJ,G\K::OT
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MA] 4><9Y\AD5F->2TB<=?03<1#>*&L:&G76<>+ ILV1NER'J-F4Q)(7D 8"
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M.^!EVV?NF3A >FG!R,0^"KW-8?=RDH< @_M+$CP373 )7 $!(; -VH !RKJ
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M9-!?5[ ;:39UN7+FBVBD+!%0:#P*211M1*$ _F:8?Z[D4YT30C=+;0/,@=H
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M] -CE=A OEK6QX='>[&X"Y/JB@7>5Y%I;6R4CW5&2N:EO8]0U8M,?$2=D[$
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M!@K+( \&PIK>)D"7.5LW3F(;44N,3L2\Y9834G+QW<-8^]]1SH[^(,#()#]
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MUR2I:"UZ:"!_E=XPKV1"RSXG!,N\ @O1YX0HK,L9^<1C9/#X1CG75!\?#L/
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MA.UOG%8B=]*;IJ]W>^D*S.YO]>_Z9<5B'^$E=WE>89,E*DBEDLK?N,"=+W3
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MR1+%S>@27#IN)T8C.8=?D9_$"I2JJ!$S4N?5NB'2Y\86O0DKLK? ;?$UBG6
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MJL:O!>P&:"+4D VZ'RICC<O_16%A'HU_&N\,6EC\<_V N^.:4YIX[@8_[BP
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M[3;P5"& %6'LXSP'S'8Q, 7RTG\F,JV40JK/:98PTFVY#QXH(VX[MBI\( (
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MZP+4DZO6C=9*4DC.4*/3HLJT*#EF_S 4KXH1QSLR:3?5E5\4Z:8BW"_1E??
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M 5;'H'/.FG%VU+0JM(WP8I\UFC&(GXWR)=BUM]#PJ;MUM(E2#<S7FV^JX04
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MQHR]^LY>0&0A%B&/<3%;*/0.\"ZD["%LE4!82%3N"'>!<(?".Q1\NH'+)(6
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MH8-#L8SS65K#WP-G"-Q\K$7 />",P2G&+P;119&A)S#/V;8$HVO J0T@(&,
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M0BN!E8=_GJ!)C?R9U(Q <I[TVJL!_RO)$$^1Z"^<TW+">F#VDA;$8N ]>[/
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M5M%/*_4GW)W!>"V?L<B;L!24!X:#R[2>@YCG>9!XJU9P[\@]"R.M*A9U>%W
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M^%%,B$(%MET3'*%VH'(N)(373A.#5^<G/YNI<)=1WE,P.\'62RND\"1+(D+
MF9A&=<I4(V-;.ASIQD6CCCG3/506.5AZF\..O?C?'O&OY']6*&8\*HH/5;.&
M@&)>Z+QCF!U43"HTO253=8R_XB1TP@QG90,/:YXGRAT("AK*J4J'L/G0MZM?
M86^K7VFK?]_;ZG=AJW_?V^J]K7YO[XLO5Q*?<(VIYWW6^LIK[2!NN3],KQ1)
M>L4/NZ [I#]ML\^*2KH !5#YO*U S-J-7'7=)3J6[42$0W7-  FU,LTQ:0EY
MR,25S:SL#[ 4Z"F[C5"5D$99SU5N[\;$=*=Z9*<N9@EI<3I\Z!'\$)38#*,F
ME>GC2\L8#MXE986Q)[3F.0L["F9@KJ.IWO[60/3>]N(\,Y14U,@ =EKV85V7
MZ9B!&]\Q'H8=<AZ![:*06_($U>\(^^(4E^20P,AMI9/-CO03P=M+T!NJ>;JT
MV,H&T^3^1"..K>EZFD(UJRV366&'DAJM,CK"ROX<6ZT15'XLRN!'+430J6T8
M2DFLV"2I.AWC7Q/:IKWPAW,GI)<G4TS7]'&3,YBA3 L(C]/B6->59.'W=P#P
M8#Z('WOA5'\*(.5%;O(D.PXH-F6Z@O"&3SWRPQ=MU-?5/V9J)1J*<-M55G![
M94T.6[[";/FAVIVMB:E9"*QN:,]*;M!AL\")FNEW.,0]U3%UL+VD,H8P6"+K
MUP$CL.C9V_(FC[)B5JRTD6C]R@"F2R#Q9G0>#JXD-+;@PXXYKMA+%:BL'],-
M52\:Z\ Z6#)8IF,F25,D.:",[3%6C6431,P5;T8'NL[^ ;;(E2V".<ZC''2,
MPTFM/0KE*A-&*34$;^7@[]96G#2M^2B!O#=H/S[U&HDC@E3L>*?]I 6%'J_6
M)0>7LDDP[Z!C;6(R=2S.I$Z!.H^6%HH+6%^J0/+I5D8G#%'!CJJ/,?LI:U"7
MB('3@)O=OBHEHZ*3\]*\N<>J<;AT_'9D%OGL$G%.N?7)5J4098^4B9 +<^::
MQ[.%O=U[$&EPM20?<<&S<B5VR#!O?A:_RF' ?0CBM)J425LJCMHXZNQ8*1D5
MM7F&_-P8J=9OWM\.88E?/H&R+7+O#Q(6%)4_0%GR>E(EG:0-Z5K":^@0H>]/
M5/M$JF5>V"DL\,8+5(77<G502B!I<Q,@1319:]>S0V<GUY-S)6SVCG14B34S
MS+O"WA9116<F@1-/LH=3+*VMUCVZ[U;HD4K@I"Y=(:W37$^NV23.KO5K5RY"
MH^BC4[Q$684L<M/W<)['U'0H%]"%1GJ)W7Z=2P'3"5][.<;$&.R<):"5PW>L
MDQ1#KFZ4ZF5VY(<$IQ#!NPF\@-^] E::X&N+%6P4N:*]?M,(PW#L_\Y+3!JO
MW5:1DA?I.9NQQI$BGW3]7DNILT@JA>[X,S4ZVD8ED:-9MM)606QUY+,+7-6Q
MP7=E J:>TR!M-^$U9EU3%,*9^ROV-9H&EC=BF[83UF'WT:9K)8P"5DX^79=F
M&)J$*L\N;>A>UU-NJU2EQV&J-,D.+40YWG03"EQ:$/]LM5LYQ)O%J=./75/R
MR>X//_P9^[5**IP*85-_1;58IZN"'<S#O51566'P [Y+B[2;,/5P8/>VV+"E
M3B3QC]AE=N:A+#V7EAANJEM(8D,*SQ-.:)5_7\<.;NDLZ8ID%Z#!?>5PT/K.
M-*<.311(E'QJIOTFTBO!V$;^X KJ:YI<@_R;K>%YDG4%#:^@%!]^[BN5YBL*
ME:)FNMX-#G-K@T2#NVI?=)!DG%@0/Z:W[W?[+\Y^>?>RJE]\B_^E?B:F[ &-
M3TY%W=3J]KQ]5;JSJ)%GL*BJ+E?25R'%[.,%-T*G&+"$9DR^B@!SP#D&@0.G
M T4W!@GK=1=XKD-*2D0N2SI7[HQVQ-I0ZAV'<$8BKU0D/%'THK Y3AX1@-"\
MT*.G:$,B6U^U$6+L&AN$)<T"04U9)^+,H=52B )66H*>*"SHI]-8I:5*EP5J
M@YJ *<K8*-5W QJ3A_?&_%VUV$#^-A&S$=?AVW &,+I!?_D<Y8Y;!;'ZUS[B
M=1<1K[_V$:^'$/&Z9T=Y^Y<U5<TO052_4Y<N![?.7+>#>R6[KB[219SK<CJB
M.B#5FTU94FPQDJ\.[\J*:C-  8$[\$]/PJ=[5$Z#=PF<@33'NVI24 )3GM14
MHT.#OU[ELVE:XY3B%9;1JU*Z?Z_ ?,!(5:X :^#^.M@/@\=[CY\J'0=-#\X$
M(5.$;>+W-!\P>'+.W]K?>_2/H,4TMG#7G(6A,5TU7QC8[_.!VO@1MB-=6#9)
MSM/87L;5B;H70C$45948%QII<E2:(CEB4<W*45JO*(H&]%E0/-%\BAHZ(JE'
MJ-#EC\26MU]#V@L7M6EUVTLBM",6P"]5"NIPF<J()NJ6XET/Z@SH,:%D!!;X
M3W0%%>N$XGPS4E+0'+2B?[44<PX'5G)<J$SQ?1?#BK5UEZHAH340@TQ0!<\R
M[8*E[$E7;_/U;E/H%^G6?[:;<B[U?NNDYB([H]4RGU 0-PSLFE4\:@[\YI1]
M;T"[1)+7=.KRG_9V]_;V":W+R4#;'0[.K< PS5F&<A(),7^N R$C)Y"\BX)#
MMIY'9L>?L*S>K;3U"LI((25)8:BYNCHRYD7W9 ;B/=?("3H!TH[!4(24<_CP
MI\=DZ6 ^*)<F8WKFM"S8H[D4D#OUM]T=SEIAH.!5V8]C?!KR%(&5-:.TPJD6
M+S72O1J0</:H349K<8?K_ !B-84<J(^DGAX9:11%(H9')Q_(@^^>'>P%R]W%
M;K"#U\-O1?DA.$;3!_/41AH!#DXAV#/[>V3'U7.VX]J -#41?0I:J(:NS3H<
M6,*3[@P8V1>*>ADN3"4:JS=B)G]6<<&]'Y 1T&1!HXO)M,HC,GAXNO[6D/-M
MNBJ1P4V0J)BZ)PT+5',"V='-,:3&.JT%30-+@@/S7@>_7"Q *]Z] 1C18U=,
MXBAIXSAE63'P]?9;DYMLN^% ]_LP_3TZDG>-J-/ D=[<5.5SEE4!(5]R$QE.
M6J_G5M\.YN]I6I+?&NYT]B?])RD+SS-S!<RB/;QVO]$;-?B/BMLW\LB=!MNJ
MEF4X:#:-;Y8[LR/>9D.4!@QQ7+DQI"":4!P2M>I&0C^[V)U%,+=61(_OGS9+
M %!-.!Z9Q=YPVYW)$0M5[2+(E">09'O:G#RM>>=CQQB<SM0DIDV2Q_[ZM"B+
M5F!-16328+&Z$FRA 42P'-$LR!! "JDC7B =_FU.(;3P;J2&P.W3Z5Z=C:63
M2\FKW5"2JK).!TG%9=URZ\@^_L?1]DC3,:ZU<RO"QIJ->__K1!-DWR8E=VP1
M8HJJHDJYDK2*QV4AUKD:5V0NU_:,JQ&5<*/8LI NUU33K?%==$,=+VW")KVC
MK\#E@B):J2SN42CT)DILRE7G'*;:D;0Q00^Q7Z.]AQ=%&H^0PBB;0J,9N JD
MEJ<.2X<:8<.-$1$/*?0')XII.?G:^W-U7 T6&\+M=,/3+7SU&*6*C<..'E %
MQ*[I8?RY$L"%CWT9:9S.Q.TK:0O,9\J5H"L#U:N-)(5X@F +%&[+VC%?/:!>
M6L2!IG=+9"M+J2$DO!_TA5H*.U1?W,+M"<XPIO+6)R/171G]U:J?,7<.")]Y
M48+1''=Y[W$T)\#3()T,]W34# :99X>#JZY[HP@R-E(4H%,*""A6H#;2&S:Z
M0INE:7RGP/HU ?,"#L)DA6P&FFVTRFI='JEV3S;9I%*>6]!#)\5D16YF)RFV
M">! UIAS]UORV'8?Z*D-!T;K ^X%_EICB:=<Y\PBV$Q!4)6)&EZ2"-SW=6IC
MC!A%XLYJ>>Z9IVJST_F'WNE\%T[G'WJG<^]TOK].YR^R)(0Y5_!A!^QH1JN?
MS9S@4&NFU9WV]'J N_G%F#3B$ )K0B<I@3_%K"N>+;.T'0*5P!\4_AAZ"C+7
MC$%US$JU>$:1A"4UO>"RS""6D9P:E^$ (^#X4(S*KLHJPH"W]7>%BH)1Y=!&
M=W,\2BN370"C"OTO"R'.RH=2*%JI>G,3PVF''"*<'QZA]:%4P+A8C>O04NY4
M2848%EWY.@U_?'L:B6X .Y(6.:!>,O6JZR1/I3EGZB/<0=E(D@FE*\ZD6(S3
M' U-"P 1805)7<2ZV!*WA_>N0KX8W6#P:@&D:1T=$PS3BQ'3@QI @9F=157%
MB-*B"CL)/11,L+(J'2)/HF6*Y? \43_+C7P<3G(NIZ$Z "(&+T)CC7!>F VR
M(L$5\6ZAY[^P&NM<*Q-LATM<R.+&+)Y5N=9D42"37>E* EW*("T7E(3B)"J3
M=S?)"W(YW'AFFY.DS* F5UF_DI+LR*ERO4(A@W%1%N(4EK'H*DD$XD*GB74V
M[VD4[/";V5^(QA%EU<3LBK8\* 0*XE9R6Z8,=D#6<Z062,;,;E*&'934#XF<
MY%,LV*G;Z@>LTO3* >$1U[MD;5LRTA&(Y..YP:S "-,/T,P:[8U$IG#Z, N#
M2,G>,GGD'LFOQ.C:_F6-Y6XW/D!&-0_> CL@Z$;5B?ULCD@K0#F?#"H!8&EE
MJ0/VC3;C+-GA0 0\RJ($(PKX95>5&3$=3]3&I:HX&_]2I][:^<P*FH>3X6KR
MI9##07FC^& .!^K4B<N%.'N3E';C6^_49 P\? MVL8W#[J%LB;,<**(1OMBA
M:%7@JG"(-UCH24#OZR;@U\1@R,JPL0+KEB?F$5($TU.O=3'P6XQ8I_(OD&W=
M\GU'U1GBG,M8<9>=A&A=#PPGBM$YHX6T%2I>(]=UU'9?FLAQKN.U(K"QRR'H
MGKD1VC/V<!MG7ZD\GQV[4S 6>BZ[Y[TX-*/;V?#6G6%Q9I<.:M"2K&( Y9>U
M)GSE;(,=%3 ( X%M4I!-S3+S5OAL ^JJ6F[QO4+Z6'-$*<Z%58%6I>X?X4).
MYU8AOJL*I&@VSN^-YNU#VKE3:YN6Z?!&R]TA7/AF=:>FHSX9OAI:$2_1ZMII
M[@TU"C2 U^8I:16)SBE2>)RLB2,UJPH=K"YL')L';N2=C3BY2?9,0*UX1[CZ
M\X_NRN@KT0DV.V+W]WI/[%UX8O?W>E=L[XKM%?S&LB:LX+\#7?<]ZKHGMIN,
M=?N3%:'KZ5M!M;[L<-4UVKGP]1.C5Z8DM8**5/ ;RSQ5Q>VNVXY]<Z!?)ZAP
M.$J]RADQ#U"!3D,%:A;CVEZI>E7FEM?'('12O=!UX"[\"7-'V4KY$?W*\M#8
M%_CMDC58,Z5($P74E&J)F=#3:=CP:856KV602K@/,PKGAX1XP#B7UL?65 0-
MT>H;,W+S/6T6\).2+2/->"S<WNU><D=NBMD% J*KF?15>I<]+UU:A^"-#J"1
M;3T9Z\5ZGV!>P%L;EDSP*8:,V&&W;<D$GV+(M%<^7F')3#=9,DW27\M,&0YN
M9*<TR;O)3#&;*66=C3D&.]>%EVV!Q/H44\49O-M0P5R&FU@J#8? C0P59U*N
M3<!HJC*W+G-E0_2AS5C9,-S(9 Z9O%VN"'5^M=%2L>:J<^ANQVX9#OZ0X>*"
MQ2@F\EK4\YXEW$53P(E*+34LG-!8-S12/3!;CB WI7&[&-TB)6NK?<\\,KV
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MM;5RD H[/A(L[^ 0H\]UO7'-@6[Z;?.08+<8T8<JCRO+SK18/:51')00/#_
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M!5_HVZ.W)[_AF?CVI_.?7[_\_U!+ P04    " "I@'98POTNAZ80  !,50
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M[9S!FTQ!72!.3X]XVZ=21U 0\4R.\OV:(:N__K(F3HNH-R=.Z[/4-6+2J]:
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MM"#J=LH\PUA;]C_BC*"*[NP2/=*D$UYE(;IJD$%W JBS(,_&BW"6ZU2S38:
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ME!23(E=RC4VH;>V<WA:4ER/CJUW-65".YW'YZYDQS)*(4N.W@/*;T7DUS0H
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MB-PG>=9-H2KA).0!&GP4PJ>6UB,B$$$^V&V/.-CMP.8T_F2&+$Z!\!<B(Y^
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ML--WH4&((H$&P<:V'B#;AA5?Y, O<QX&4>^+BKI8DAJ^CI+ @!<'WU$A_N?
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M;E>DM>5NQ->J@1/W%UCVDT6VF)Q"AO^#=\'R2OFQ(N6_C+RP]DT5.$\U[_<
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M^I^B=(/^&;;_=]GTS[?_#5!+ P04    " "I@'98K,D4W$X8  #9Q0  "P
M &9O<FTX+6LN:'1M[5UK=]HZUO[.K]#+G M9P\W<$I(TLR@A+6V:9$(Z[3E?
MLH0M0(UOM>P$SJ]_]Y8OV&!R*R2!9-:9MEBRM"4]^ZHM>?\_8T,GU\P1W#+?
M_:D4RW\29JJ6QLWANS];O7:W^^=_#C+[(Q>J0553O,N.7-?>+95N;FZ*-]6B
MY0Q+2K/9+(VQ3M:OM#M.K5<IEY72]R_'/77$#%K@IG"IJ;+H)9V;5XO;Q]*H
M:M_1>:(J/@D[J9;FFH92;?I"O'*CY!<FJKJI5>M^53>LRH55JRC;M]'AUXA>
M&"^JJR#-,$+V_?WY\;2ZFUY_6K7D.M04 \LQJ M+B"W5"^5*H=*(-5(03$TT
M!+^+0^OZSG9V"E4E;&=N<9(CQ>(^%=&,:VQFNL,^H0#>J%3#B@X;+&RV48+2
ML*(G"D-*[:CR@(J^K!@4)%J%9XZE,Y%:6Y8DJJN69[K.))WBH##Q@G#<^:;A
M8:+2]U;W/*K59Q/+U"AWBB:3U6KE:J6<1>9B5#O($/S?OLM=G1WLE_R_,_L&
M<RG!%@KLI\>OWV7;ENDRTRU<3&R8:]7_]2[KLK%;DAQ8@K=*?I/[_U<HD"/.
M=&V7])B[1TZHP7;)6!OOD>ZA_,=EN=*^_-K[O7+XH=4Z@[^0?E(HW//E:OT2
M!WF9&-QE.+C[MU,[C%YZQ-OUYB4#6 'U\%_+8*8&_W>/=#J\'%!=L >TM!UK
MJ6/"*DS:T)1#]:ZIL?%G-KDL@Q!KU)1&5;E_LXWW,,>'E\IE( _\]N'1 YJH
M7/9&U&'BLG(II9_?AI#/'M#,(5)R%C15G2-H4=M]2YL0X4YT]BX[ -#M$J5L
MN^2"&U#CA-V0<\N@9MY_D(?^'3Y ;&O\.GQ-X\+6Z627F);)L(R/=Q&GS 'P
MRQ]<TYB)G("_H-:)9T [JH_RL7N.DJ(E3@>(D$*Y6@#V(28,$MIF?#>Q\%G"
MM7=9/KXNU)K;V0,)@_U2HME'=Y2*BWB'.]F#*4K2>BW%1XLT@)AC#BA>)F0Y
M"M-=(;4DT$*DZML=24DY!B8KA"Q2' LM&Q2[(!#>904W;)VA$ BZ2;3L=R4L
MSPEZ@DIRP7>#D<M!S(P\$$UA329''SZ,'G,-"P:<.402SE(53KO[.3DWLR]'
MG972>@OZLF$B+6V.!%#YCGM(778PI3YL9UHV^Q: 9L$[8<D,2?'>PV?!]"6F
MU#.Y/Y_ 5K.3:# J/(<=!.RW"U7"IL*B1/O85GKC/B<O:C\8O*SSR ZFXF*V
M$^!M6+BY"<4W)=BI:SG3T@>/?9:\E#9C/1XRTS*X>4>?=\[';*<IS8;%\>'/
M3F/ >E-.\UD^D';[)7CW()/)[-L/E:E[Q*#.D)N[!*N6]PC"KD!U/H1'*G +
M<[('^\*F9KSEPH :7 ?1>T?;LJ[@_S"?%&BI?_#'OY1&>6^_U >K!-N%O^R#
M]2!]GNB8BCSW=%8XHT-I'<3UU W7W!&V4OX]FRCH6PXL7\&U[%WR7J?J%:G!
M0(2E<VV/!(5]RW4M(RQ7BO5IC3B%2& XL8B%X,\8>:4$?>LQWVL(E9V ]*\G
MW8O.8:9WT;KH]-9R!+U.^^MY]Z+;Z65:)X>D\[W]L77RH4/:IU^^='N][NG)
M6@VK$@SK&Q4C;@Y=R\QG#HOM(JF4Z[7F6@VE'.?V-:$Y1-71Z?F7C-\B&@/H
M0S3+.]))*A0.+=5#@QM]T4LU<N"FKMP_-\*X^/N+9GY3*33W&&,[WL?4QJXK
M8&/O%#[/&M?1_+[!XTDD/HB<\\[)1>:\<W9Z?K%^TPY#./,<X5'3S;@65%,Q
M^D64*K$<HM1SVM9:CLD:9-P1P^%X#G<YO-X9JR-J@C'14EUB#8C2K-;6;VCK
MR"7H0F9@QL^9;3DNR>%O7 %&P6%@PB7L&OHDCBQFVM8N0<LUWKVD3V.JY<C8
M["[Q3# U,7(;TCD5S>T9T7PFG=6.[\FFRVCEXJJO:O1::]4?)*/]8#'*8W=7
M@]8-J#O2Z&0"(V-FF@Q/$!,7YLWLP1?JJ"-0[GF"?2R4ZV_B_2FU_Z-A^#Z
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M)NR]EJ8Y3(C@KV-N,B7=UMO^2D\GYV?_#/^W\TNV7DJ'<3NOECUHELN9GLO
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M;P&LM]C-BNE+4E;J6]H$F*@T<@W]X/\!4$L#!!0    ( *F =EA24E<Q*@,
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M@XM*L8#@CIXEZXB#4/2DIHXR9/P,LIOKX]"/PZ.HB_QV,3.[V<G"%IM9ZL(
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M'1]J,Y;/BWGJH7&5S8U'3XM'+ _@[39+U0PJC<%7P3N#'-]>&-  XR9#1T1
MZ VP"=UPR"-1'OH!%<&H%NWI_"P]9 $D\>?]/7D@0KUWL"2[[+/<T5/'&<:
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M?=PJS>LQM!_*L7ND4. X6R1#]NI&G27,T*2HTI )(F(;4NWVM7FB\^I4T ;
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MWL)JC_P/4$L! A0#%     @ J8!V6+"V>*:#20  U](!  D
M ( !     &5X,2TQ+FAT;5!+ 0(4 Q0    ( *F =EC3B2[-^:   "GJ P *
M              "  :I)  !E>#$P+3$N:'1M4$L! A0#%     @ J8!V6*[#
M2V=M3P  VR0"  D              ( !R^H  &5X-"TQ+FAT;5!+ 0(4 Q0
M   ( *F =EC"_2Z'IA   $Q5   )              "  5\Z 0!E>#4M,2YH
M=&U02P$"% ,4    " "I@'98>B?5UA00  #%/0  "@              @ $L
M2P$ 97@Y.2TQ+FAT;5!+ 0(4 Q0    ( *F =EBLR13<3A@  -G%   +
M          "  6A; 0!F;W)M."UK+FAT;5!+ 0(4 Q0    ( *F =EA24E<Q
M*@,  .8+   1              "  =]S 0!X86ER+3(P,C0P,S(P+GAS9%!+
M 0(4 Q0    ( *F =EC]' +[_0H  ("&   5              "  3AW 0!X
M86ER+3(P,C0P,S(P7VQA8BYX;6Q02P$"% ,4    " "I@'98_GM5C5@'  #7
M5P  %0              @ %H@@$ >&%I<BTR,#(T,#,R,%]P<F4N>&UL4$L%
3!@     )  D $P(  /.) 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xair-20240320.xsd" xlink:type="simple"/>
    <context id="AsOf2024-03-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001641631</identifier>
        </entity>
        <period>
            <startDate>2024-03-20</startDate>
            <endDate>2024-03-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-03-20" id="ixv-497">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-03-20" id="ixv-498">0001641631</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-03-20" id="ixv-518">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-03-20" id="ixv-519">2024-03-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-03-20" id="ixv-520">BEYOND AIR, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-03-20" id="ixv-521">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-03-20" id="ixv-522">001-38892</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-03-20" id="ixv-523">47-3812456</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-03-20" id="ixv-524">900 Stewart Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-03-20" id="ixv-525">Suite 301</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-03-20" id="ixv-526">Garden City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-03-20" id="ixv-527">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-03-20" id="ixv-528">11530</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-03-20" id="ixv-529">(516)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-03-20" id="ixv-530">665-8200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-03-20" id="ixv-531">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-03-20" id="ixv-532">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-03-20" id="ixv-533">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-03-20" id="ixv-534">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-03-20" id="ixv-535">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="AsOf2024-03-20" id="ixv-536">Common     Stock, par value $.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-03-20" id="ixv-537">XAIR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-03-20" id="ixv-538">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139628424266592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 20, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 20,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BEYOND
AIR, INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001641631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3812456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">900
Stewart Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Garden
City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(516)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">665-8200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XAIR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
